合成路线1
该中间体在本合成路线中的序号:
(X) The condensation of 2,4-dichloro-5-fluorobenzoyl chloride (I) with diethyl malonate (II) by means of magnesium ethoxide in ether gives diethyl 2,4-dichloro-5-fluorobenzoylmalonate (III), which is partially hydrolyzed and decarboxylated with p-toluenesulfonic acid water yielding ethyl 2,4-dichloro-5-fluorobenzoylacetate (IV). The condensation of (IV) with triethyl orthoformate (V) in refluxing acetic anhydride affords ethyl 2-(2,4-dichloro-5-fluorobenzoyl)-3-ethoxyacrylate (VI), which is treated with cyclopropylamine (VII) in ethanol to give ethyl 2-(2,4-dichloro-5-fluorobenzoyl)-3-cyclopropylaminoacrylate (VIII). The cyclization of (VIII) with NaH in refluxing dioxane yields 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (IX), which is finally condensed with piperazine (X) in hot DMSO.
【1】
Reddy, P.G.; Baskaran, S.; Microwave assisted amination of quinolone carboxylic acids: An expeditious synthesis of fluoroquinolone antibacterials. Tetrahedron Lett 2001, 42, 38, 6775.
|
【2】
Grohe, K.; Zeiler, H. J.; Metzger, K.G. (Bayer AG); 1-Cyclopropyl-6-fluoro-1,4-dihidro-4-oxo-7-piperazino-quinoline-3-carboxilic acids, process for their preparation and antibacterial agents containing them. EP 0078362; JP 4253963; JP 58074667 .
|
【3】
Serradell, M.N.; Castaner, J.; Ciprofloxacin. Drugs Fut 1984, 9, 3, 179.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22093 |
2,4-dichloro-5-fluorobenzoyl chloride
|
86393-34-2 |
C7H2Cl3FO |
详情 | 详情
|
(II) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(III) |
22095 |
diethyl 2-(2,4-dichloro-5-fluorobenzoyl)malonate
|
|
C14H13Cl2FO5 |
详情 |
详情
|
(IV) |
22096 |
ethyl 3-(2,4-dichloro-5-fluorophenyl)-3-oxopropanoate
|
|
C11H9Cl2FO3 |
详情 |
详情
|
(V) |
21304 |
Triethyl orthoformate; 1-(Diethoxymethoxy)ethane; Diethoxymethyl ethyl ether
|
122-51-0 |
C7H16O3 |
详情 | 详情
|
(VI) |
22098 |
ethyl (Z)-2-(2,4-dichloro-5-fluorobenzoyl)-3-ethoxy-2-propenoate
|
|
C14H13Cl2FO4 |
详情 |
详情
|
(VII) |
12263 |
Cyclopropylamine; Cyclopropanamine
|
765-30-0 |
C3H7N |
详情 | 详情
|
(VIII) |
22100 |
ethyl (E)-3-(cyclopropylamino)-2-(2,4-dichloro-5-fluorobenzoyl)-2-propenoate
|
|
C15H14Cl2FNO3 |
详情 |
详情
|
(IX) |
30340 |
ethyl 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
86483-54-7 |
C15H13ClFNO3 |
详情 | 详情
|
(X) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(IV) The reaction of cyclohexylamine (I) with chloroacetyl chloride (II) in water in the presence of sodium hydroxide gives N-cyclohexyl-2-chloro-acetamide (III), which by reaction with piperazine (IV) in water is converted to N-[(N-cyclohexylcarbamoyl)methyl]piperazine (V). This compound is then treated with one equivalent of HCl.
【1】
Corvi-Mora, C. (Camillo Corvi SpA); N-Cyclohexyl-piperazino acetamides and propionamides. US 4123530; US 4278796 .
|
【2】
de Angelis, L.; Esaprazole hydrochloride. Drugs Fut 1986, 11, 4, 263.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17966 |
cyclohexanamine; cyclohexyl amine; cyclohexylamine
|
108-91-8 |
C6H13N |
详情 | 详情
|
(II) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(III) |
27377 |
2-chloro-N-cyclohexylacetamide
|
|
C8H14ClNO |
详情 |
详情
|
(IV) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(V) |
27378 |
N-cyclohexyl-2-(1-piperazinyl)acetamide
|
|
C12H23N3O |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(V) The earlier synthesis starts with the reaction of 4-chloro-7-(trifluoromethyl)quinoline (I) with 4-aminobenzoic acid (II) in ethanol-HCl giving 4-(4-carboxyphenylamino)-7-(trifluoromethyl)quinoline (III), which is converted to its acyl chloride (IV) by treatment with SOCl2. The reaction of (IV) with piperazine (V) yields 1-[4-[7-(trifluoromethyl)quinolin-4-ylamino]benzoyl]piperazine (VI), which is finally acylated with 4-fluorobenzenesulfonyl chloride (VII) to give U-54669 F. However, this method is not economically efficient, since the most expensive compound [quinoline (I)] is already used in the first step of the synthesis.
【1】
McCall, J.M. (Pharmacia Corp.); Aminoquinolines. GB 2021567 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20003 |
4-chloro-7-(trifluoromethyl)quinoline
|
346-55-4 |
C10H5ClF3N |
详情 | 详情
|
(II) |
20004 |
p-aminobenzoic acid; 4-aminobenzoic acid
|
150-13-0 |
C7H7NO2 |
详情 | 详情
|
(III) |
20005 |
4-[[7-(trifluoromethyl)-4-quinolinyl]amino]benzoic acid
|
|
C17H11F3N2O2 |
详情 |
详情
|
(IV) |
20006 |
4-[[7-(trifluoromethyl)-4-quinolinyl]amino]benzoyl chloride
|
|
C17H10ClF3N2O |
详情 |
详情
|
(V) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(VI) |
20008 |
1-piperazinyl(4-[[7-(trifluoromethyl)-4-quinolinyl]amino]phenyl)methanone
|
|
C21H19F3N4O |
详情 |
详情
|
(VII) |
12292 |
4-Fluorobenzenesulfonyl chloride
|
349-88-2 |
C6H4ClFO2S |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(II) The condensation of 4-nitrobenzoyl chloride (I) with piperazine (II) in water by means of KOH gives 4-nitrobenzoylpiperazine (III), which is reduced with H2 over Pd/C in methanol yielding 4-aminobenzoyl piperazine (IV). The condensation of (IV) with 4-chloro-7-trifluoromethylquinoline (V) by means of HCl in refluxing ethanol affords 4-[4-[[7-(trifluoromethyl)-4-quinolinyl]amino]benzoyl]piperazine (VI), which is finally acylated with 4-fluorobenzenesulfonyl chloride (VII) by means of triethylamine in THF.
【1】
McCall, J.M. (Pharmacia Corp.); Aminoquinolines. GB 2021567 .
|
【2】
Castaner, J.; Serradell, M.N.; U-54669-F. Drugs Fut 1984, 9, 1, 36.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18941 |
p-nitrobenzoyl chloride; 4-nitrobenzoyl chloride
|
122-04-3 |
C7H4ClNO3 |
详情 | 详情
|
(II) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(III) |
20011 |
(4-nitrophenyl)(1-piperazinyl)methanone
|
|
C11H13N3O3 |
详情 |
详情
|
(IV) |
20014 |
(4-aminophenyl)(1-piperazinyl)methanone
|
|
C11H15N3O |
详情 |
详情
|
(V) |
20003 |
4-chloro-7-(trifluoromethyl)quinoline
|
346-55-4 |
C10H5ClF3N |
详情 | 详情
|
(VI) |
20008 |
1-piperazinyl(4-[[7-(trifluoromethyl)-4-quinolinyl]amino]phenyl)methanone
|
|
C21H19F3N4O |
详情 |
详情
|
(VII) |
12292 |
4-Fluorobenzenesulfonyl chloride
|
349-88-2 |
C6H4ClFO2S |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(I) The acylation of piperazine (I) with 1,4-benzodioxan-2-ylcarbonyl chloride (II) by means of sodium acetate in water-acetone gives N-(1,4-benzodioxan-2-carbonyl)piperazine (III), which is then condensed with 4-amino-2-chloro-6,7-dimethoxyquinazoline (IV) in refluxing butanol.
【1】
Campbell, S.F. (Pfizer Inc.); Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines. DE 2847623; FR 24079529; US 4188390 .
|
【2】
Serradell, M.N.; Castaner, J.; Blancafort, P.; Doxazosin. Drugs Fut 1982, 7, 12, 877.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(II) |
32160 |
2,3-dihydro-1,4-benzodioxine-2-carbonyl chloride
|
|
C9H7ClO3 |
详情 |
详情
|
(III) |
32161 |
2,3-dihydro-1,4-benzodioxin-2-yl(1-piperazinyl)methanone
|
|
C13H16N2O3 |
详情 |
详情
|
(IV) |
10443 |
2-Chloro-6,7-dimethoxy-4-quinazolinamine; 4-Amino-2-chloro-6,7-dimethoxyquinazoline; 2-Chloro-6,7-dimethoxy-4-quinazolinylamine
|
23680-84-4 |
C10H10ClN3O2 |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(X) The condensation of 2-amino-7-hydroxy-1,8-naphthyridine (I) with 5,6-dihydro-1,7-dithiin-2,3-dicarboxylic acid anhydride (II) in biphenyl-diphenyl ether at 230 C gives 5,7-dioxo-8-(7-hydroxy-1,8-naphthyridin-2-yl)-2,3,6,7-tetrahydro-5H-1,4-dithiino[2,3-c]pyrrole (III), which by reaction with POCl3 at 100 C is converted to the corresponding 7-chloro derivative (IV). Partial reduction of (IV) with KBH4 in methanol yields 6-(7-chloro-1,8-naphthyridin 2-yl)-5-hydroxy-7-oxo-2,3,6,7-tetrahydro-5H-1,4-dithiino[2,3-c]pyrrole (V), which is condensed with 4-chlorocarbonyl-1-(tert-butoxycarbonyl)piperazin (VI) by means of NaH in DMF affording 5-[(4-tert-butoxycarbonylpiperazin-1-yl)carbonyloxy]-6-(7-chloro-1,8-naphthyndin-2-yl)-7-oxo-2,3,6,7-tetrahydro-5H-1,4-dithiino[2,3-c]pyrrole (VII) Deprotection of (VII) by means of trifluoroacetic acid gives 6-(7-chloro-1,8-naphthyridin-2-yl)-7-oxo-5-[(piperazin-1-yl)carbonyloxy]-2,3,6,7-tetrahydro-5H-1,4-dithino[2,3-c]pyrrole (VIII), which is finally acetylated with propionic acid (IX) by means of dicyclohexylcarbodiimide in methylene chloride.
The piperazine derivative (VI) is prepared as follows: The condensation of piperazine (X) with tert-butyl azidoformate (XI) in aqueous HCl gives 1-(tert-butoxycarbonyl)piperazine (XII), which is then condensed with phosgene in anhydrous toluene.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
28994 |
7-amino[1,8]naphthyridin-2-ol
|
|
C8H7N3O |
详情 |
详情
|
(II) |
28995 |
2,3-dihydro-5H-[1,4]dithiino[2,3-c]pyrrole-5,7(6H)-dione
|
|
C6H5NO2S2 |
详情 |
详情
|
(III) |
28996 |
6-(7-hydroxy[1,8]naphthyridin-2-yl)-2,3-dihydro-5H-[1,4]dithiino[2,3-c]pyrrole-5,7(6H)-dione
|
|
C14H9N3O3S2 |
详情 |
详情
|
(IV) |
28997 |
6-(7-chloro[1,8]naphthyridin-2-yl)-2,3-dihydro-5H-[1,4]dithiino[2,3-c]pyrrole-5,7(6H)-dione
|
|
C14H8ClN3O2S2 |
详情 |
详情
|
(V) |
28998 |
6-(7-chloro[1,8]naphthyridin-2-yl)-7-hydroxy-2,3,6,7-tetrahydro-5H-[1,4]dithiino[2,3-c]pyrrol-5-one
|
|
C14H10ClN3O2S2 |
详情 |
详情
|
(VI) |
28999 |
tert-butyl 4-(chlorocarbonyl)-1-piperazinecarboxylate
|
|
C10H17ClN2O3 |
详情 |
详情
|
(VII) |
29000 |
1-(tert-butyl) 4-[6-(7-chloro[1,8]naphthyridin-2-yl)-7-oxo-2,3,6,7-tetrahydro-5H-[1,4]dithiino[2,3-c]pyrrol-5-yl] 1,4-piperazinedicarboxylate
|
|
C24H26ClN5O5S2 |
详情 |
详情
|
(VIII) |
29001 |
6-(7-chloro[1,8]naphthyridin-2-yl)-7-oxo-2,3,6,7-tetrahydro-5H-[1,4]dithiino[2,3-c]pyrrol-5-yl 1-piperazinecarboxylate
|
|
C19H18ClN5O3S2 |
详情 |
详情
|
(IX) |
20178 |
propionic acid
|
79-09-4 |
C3H6O2 |
详情 | 详情
|
(X) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(XI) |
29002 |
2-[(azidocarbonyl)oxy]-2-methylpropane
|
|
C5H9N3O2 |
详情 |
详情
|
(XII) |
13225 |
N-tert-Butoxycarbonyl piperazine; tert-butyl 1-piperazinecarboxylate;tert-butyl piperazine-1-carboxylate |
143238-38-4 |
C9H18N2O2 |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
(II) By condensation of 2-chloro-6-nitroquinoline (I) with piperazine in refluxing xylene.
【1】
Mebius, E.J. (Duphar International Research BV); Farmacologisch wekzame 2-(1-piperazinyl)-chinolinederivaten. NL 7904723 .
|
【2】
Castaner, J.; Serradell, M.N.; Owen, R.T.; DU-24565. Drugs Fut 1985, 10, 5, 385.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29328 |
2-chloro-6-nitroquinoline
|
|
C9H5ClN2O2 |
详情 |
详情
|
(II) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(II) The reaction of cyclopropylmethyl chloride or cyclopropylmethyl bromide (Ia-b) with piperazine (II) by means of Na2CO3 in anhydrous DMF gives N,N-dicyclopropylmethylpiperazine.
【1】
Robba, M.F.; Aurousseau, M.E. (Laboratoire Innothera SA); Cyclopropylmethyl piperazines, the process for preparing the same and their use in therapeutics. CA 1171085; EP 81401516; FR 8021527; JP 163681; US 4474783 .
|
【2】
Leclerc, G.; INO-2628 CZ. Drugs Fut 1985, 10, 11, 907.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(Ib) |
22277 |
Cyclopropyl bromide; 1-(Bromomethyl)cyclopropane
|
7051-34-5 |
C4H7Br |
详情 | 详情
|
(Ia) |
29776 |
1-(chloromethyl)cyclopropane
|
5911-08-0 |
C4H7Cl |
详情 | 详情
|
(II) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(II) By condensation of 1-ethyl-6-fluoro-7-chloro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid (I) with piperazine (II) by heating at 170 C in water in a pressure tube.
【1】
Blancafort, P.; Sweetman, A.J.; Castaner, J.; Serradell, M.N.; AM-715. Drugs Fut 1981, 6, 8, 462.
|
【2】
Irikura, T. (Kyorin Pharmaceutical Co., Ltd.); Piperazinyl derivs. of quinoline carboxylic acids. US 4146719 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32076 |
7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
68077-26-9 |
C12H9ClFNO3 |
详情 | 详情
|
(II) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(I) The total synthesis of picumast dihydrochloride has been described:
The alkylation of piperazine (I) with 4-chlorobenzyl chloride (II) in ethanol gives 1-(4-chlorobenzyl)piperazine (III), which is alkylated again with 1-bromo-3-chloropropane (IV) by means of triethylamine in a suitable solvent to yield 1-(4-chlorobenzyl)-4-(3-chloropropyl)piperazine (V). Finally, this compound is condensed with 7-hydroxy-3,4-dimethylcoumarin (VI) by means of K2CO3 in refluxing butanone.
Compound (VI) is obtained by cyclization of resorcinol (VII) with ethyl 2-methylacetoacetate (VIII) by means of refluxing acetic acid containing HCl.
【1】
Witte, E.-C.; Chemical synthesis of picumast dihydrochloride. Arzneim-Forsch Drug Res 1989, 39, 10a, 1309.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(II) |
10356 |
1-Chloro-4-(chloromethyl)benzene; 4-Chlorobenzyl chloride
|
104-83-6 |
C7H6Cl2 |
详情 | 详情
|
(III) |
10357 |
1-(4-Chlorobenzyl)piperazine; N-(4-Chlorobenzyl)piperazine
|
|
C11H15ClN2 |
详情 |
详情
|
(IV) |
10358 |
1-Bromo-3-chloropropane
|
109-70-6 |
C3H6BrCl |
详情 | 详情
|
(V) |
10359 |
1-(4-Chlorobenzyl)-4-(3-chloropropyl)piperazine
|
|
C14H20Cl2N2 |
详情 |
详情
|
(VI) |
10360 |
3,4-Dimethylumbelliferone; 7-Hydroxy-3,4-dimethyl-2H-chromen-2-one
|
2107-78-0 |
C11H10O3 |
详情 | 详情
|
(VII) |
10361 |
1,3-Dihydroxybenzene; m-Dihydroxybenzene; Resorcinol; Resorcin; 1,3-Benzenediol
|
108-46-3 |
C6H6O2 |
详情 | 详情
|
(VIII) |
10362 |
ethyl 2-methyl-3-oxobutanoate; ethyl 2-methylacetoacetate
|
609-14-3 |
C7H12O3 |
详情 | 详情
|
合成路线11
该中间体在本合成路线中的序号:
(A) The condensation of 11-amino-2-chlorodibenzo[b,f][1,4]oxazepine (IV) with piperazine (A) by means of aluminum chloride at 100 C.
【1】
Howell, C.F.; et al.; Nouveau procédé pour la préparation des 11-tert-aminodibenz[b,f][1,4]oxazépines et thiazépines. DE 1645954; ES 335760; FR 1508536; US 3444169 . |
【2】
Playle, A.C.; Castaner, J.; Amoxapine. Drugs Fut 1976, 1, 11, 511.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(IV) |
34090 |
2-chlorodibenzo[b,f][1,4]oxazepin-11-amine; 2-chlorodibenzo[b,f][1,4]oxazepin-11-ylamine
|
|
C13H9ClN2O |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(II) Condensation of bis(4-fluorophenyl)methyl 2-chloroethyl ether (I) with piperazine (II) in refluxing toluene afforded the monosubstituted piperazine (III). This was then alkylated with (3-bromopropyl)benzene (IV) in boiling EtOH to furnish the title compound.
【1】
Gootjes, J. (Gist-Brocades NV); Piperazine derivs., process for their preparation and their use. DE 2755752; US 4202896 .
|
【2】
Van der Zee, P.; et al.; Aryl 1,4-dialk(en)ylpiperazines as selective and very potent inhibitors of dopamine uptake. Eur J Med Chem 1980, 15, 4, 363.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
54931 |
1-[(2-chloroethoxy)(4-fluorophenyl)methyl]-4-fluorobenzene; bis(4-fluorophenyl)methyl 2-chloroethyl ether
|
|
C15H13ClF2O |
详情 |
详情
|
(II) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(III) |
54932 |
1-{2-[bis(4-fluorophenyl)methoxy]ethyl}piperazine; bis(4-fluorophenyl)methyl 2-(1-piperazinyl)ethyl ether
|
|
C19H22F2N2O |
详情 |
详情
|
(IV) |
20884 |
1-(3-bromopropyl)benzene
|
637-59-2 |
C9H11Br |
详情 | 详情
|
合成路线13
该中间体在本合成路线中的序号:
(II) 1-(3-Phenylpropyl)piperazine (III) has been obtained by condensation of 3-phenylpropyl bromide (I) with piperazine (II) in refluxing acetonitrile.
The condensation of bis(4-fluorophenyl)methanol (IV) with 2-chloroethanol (V) by means of sulfuric acid gives the 2-chloroethyl bis(4-fluorophenyl)methyl ether (VI), which si treated with NaI to yield the corresponding iodo derivative (VII). Finally this compound is condensed with the intermediate piperazine (III) by means of aq. Na2CO3 to afford the target disubstituted piperazine.
【1】
Zhang, J.; Ironside, M.D.; Sugathapala, P.M.; Robertson, J.; Darey, M.C.P.; Scale-up synthesis of the dopamine uptake inhibitor GBR-12909. Org Process Res Dev 2002, 6, 5, 621.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20884 |
1-(3-bromopropyl)benzene
|
637-59-2 |
C9H11Br |
详情 | 详情
|
(II) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(III) |
38636 |
1-(3-phenylpropyl)piperazine
|
|
C13H20N2 |
详情 |
详情
|
(IV) |
41974 |
4,4'-Difluorobenzhydrol; bis(4-Fluorophenyl)methanol; alpha-(4-fluorophenyl)benzenemethanol; 4-fluoro-alpha-(4-fluorophenyl)benzenemethanol
|
365-24-2 |
C13H10F2O |
详情 | 详情
|
(V) |
10384 |
2-Chloro-1-ethanol; Ethylene chlorohydrin
|
107-07-3 |
C2H5ClO |
详情 | 详情
|
(VI) |
54931 |
1-[(2-chloroethoxy)(4-fluorophenyl)methyl]-4-fluorobenzene; bis(4-fluorophenyl)methyl 2-chloroethyl ether
|
|
C15H13ClF2O |
详情 |
详情
|
(VII) |
56868 |
bis(4-fluorophenyl)methyl 2-iodoethyl ether; 1-fluoro-4-[(4-fluorophenyl)(2-iodoethoxy)methyl]benzene
|
|
C15H13F2IO |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(IV) 1) The acylation of 2,6-dimethylaniline (II) with chloroacetyl chloride by means of triethylamine in dichloromethane gives N-(2,6-dimethylphenyl) chloroacetamide (III), which is condensed with piperidine (IV) in refluxing ethanol to yield N-(2,6-dimethylphenyl)-2-piperazinoacetamide IV). Finally, this compound is condensed with 3-(2-methoxyphenoxy)-12-epoxypropane (VI) in refluxing methanol toluene.
【1】
Ainsworth, A.T.; Smith, D.G. (SmithKline Beecham plc); Ethanamine derivs., their preparation and use in pharmaceutical compsns. EP 0023385 .
|
【2】
Prous, J.; Castaner, J.; RANOLAZINE < Rec INN; USAN >. Drugs Fut 1988, 13, 9, 837.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(II) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(III) |
24100 |
2-chloro-N-(2,6-dimethylphenyl)acetamide
|
2198-53-0 |
C10H12ClNO |
详情 | 详情
|
(IV) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(V) |
24102 |
N-(2,6-dimethylphenyl)-2-(1-piperazinyl)acetamide
|
|
C14H21N3O |
详情 |
详情
|
(VI) |
24103 |
2-[(2-methoxyphenoxy)methyl]oxirane
|
|
C10H12O3 |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(IV) 2) The condensation of epoxide (VI) with piperazine (IV) in refluxing isopropanol gives 1-[3-(2-methoxyphenoxy)-2-hydroxypropyl]piperazine (VII), which is then condensed with chloroacetamide (III) in refluxing ethanol.
【1】
Ainsworth, A.T.; Smith, D.G. (SmithKline Beecham plc); Ethanamine derivs., their preparation and use in pharmaceutical compsns. EP 0023385 .
|
【2】
Prous, J.; Castaner, J.; RANOLAZINE < Rec INN; USAN >. Drugs Fut 1988, 13, 9, 837.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(II) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(III) |
24100 |
2-chloro-N-(2,6-dimethylphenyl)acetamide
|
2198-53-0 |
C10H12ClNO |
详情 | 详情
|
(IV) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(VI) |
24103 |
2-[(2-methoxyphenoxy)methyl]oxirane
|
|
C10H12O3 |
详情 |
详情
|
(VII) |
24109 |
1-(2-methoxyphenoxy)-3-(1-piperazinyl)-2-propanol
|
|
C14H22N2O3 |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
(VI) Reaction of the dicarboxylic acid (I) with thionyl chloride in hot toluene gives the di-acid chloride (II). Treatment of (II) with Cl2 in CH2Cl2 gives the sulfenyl chloride (III), which upon reaction with NH4OH affords the benzisothiazole (IV). Chlorination of (IV) in heat POCl3 yields the chlorobenzisothiazole (V). Reaction of (V) and piperazine (VI) in excess molten pipeazine gives the monosubstituted piperazine (VII). Reaction of (VII) with the dibromide (VIII) in refluxing ethanol yields the spiroquaternary (IX). Finally, BMY-13859-1 is obtained by treatment of (IX) with the glutarimide (X) in refluxing xylene followed by treatment with HCl in isopropanol.
【1】
Eison, M.S.; Taylor, D.P.; New, J.S.; Minielli, J.L.; BMY-13859. Drugs Fut 1985, 10, 9, 731.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10404 |
Ethyl vanillin; 3-Ethoxy-4-hydroxybenzaldehyde
|
121-32-4 |
C9H10O3 |
详情 | 详情
|
(II) |
10405 |
2-Chloro-2-[3-ethoxy-4-(pentyloxy)phenyl]acetonitrile
|
|
C15H20ClNO2 |
详情 |
详情
|
(III) |
28018 |
2-(chlorosulfanyl)benzoyl chloride
|
|
C7H4Cl2OS |
详情 |
详情
|
(IV) |
16278 |
1,2-benzisothiazol-3(2H)-one; 1,2-Benzisothiazolin-3-one
|
2634-33-5 |
C7H5NOS |
详情 | 详情
|
(V) |
16279 |
3-chloro-1,2-benzisothiazole
|
|
C7H4ClNS |
详情 |
详情
|
(VI) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(VII) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
(VIII) |
11883 |
1,4-Dibromobutane; 1,4-Butylene bromide
|
110-52-1 |
C4H8Br2 |
详情 | 详情
|
(IX) |
28019 |
8-(1,2-benzisothiazol-3-yl)-8-aza-5-azoniaspiro[4.5]decane bromide
|
|
C15H20BrN3S |
详情 |
详情
|
(X) |
28020 |
8-azaspiro[4.5]decane-7,9-dione
|
1075-89-4 |
C9H13NO2 |
详情 | 详情
|
合成路线17
该中间体在本合成路线中的序号:
(I) The condensation of piperazine (I) with [14C]-labeled 2-chloropyrimidine (II) in refluxing ethanol gives the labeled 1-(2-pyrimidinyl)piperazine (III), which is then condensed with the N-(4-bromobutyl)imide (IV) by means of K2CO3 and KI as before, affording SM-3997 labeled at the pyrimidine ring.
【1】
Kanamaru, H.; Nishioka, K.; 14C-labeling of a novel anxiolytic agent tandospirone. J Label Compd Radiopharm 1992, 31, 6, 427.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(II) |
11191 |
2-Chloropyrimidine
|
1722-12-9 |
C4H3ClN2 |
详情 | 详情
|
(II) |
45056 |
2-chloropyrimidine
|
|
C4H3ClN2 |
详情 |
详情
|
(III) |
11175 |
2-(1-Piperazinyl)pyrimidine; 2-Piperazinopyrimidine; N-(Pyrimidinyl)piperazine
|
20980-22-7 |
C8H12N4 |
详情 | 详情
|
(III) |
45057 |
2-(1-piperazinyl)pyrimidine
|
|
C8H12N4 |
详情 |
详情
|
(IV) |
11174 |
(1R,2S,6R,7S)-4-(4-Bromobutyl)-4-azatricyclo[5.2.1.0(2,6)]decane-3,5-dione
|
|
C13H18BrNO2 |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(II) The reaction of furoyl chloride (I) with piperazine (II) by means of NaOH in water gives N-(2-furoyl)piperazin (III), which is reduced with H2 over Raney-Ni in methanol to afford N-(tetrahydro-2-furoyl)piperazine (IV) . Finally, this compound is condensed with 2-chloro-4-amino-6,7-dimethoxyquinazoline (V) in refluxing methoxyethanol.
【1】
Winn, M.; Kyncl, J.; Dunnigan, D.A.; Jones, P.H. (Abbott Laboratories Inc.); Antihypertensive agents. CA 1057754; CH 602712; DE 2646186; FR 2327787; GB 1517403; JP 52048678; US 4026894; US 4112097 .
|
【2】
Roteman, R. (Abbott Laboratories Inc.); 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate. CA 1081229; DE 2831112; FR 2399430; JP 54027588 .
|
【3】
Thorpe, P.; Castaner, J.; Serradell, M.N.; Blancafort, P.; Terazosin Hydrochloride. Drugs Fut 1983, 8, 1, 45.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26093 |
2-Furoyl chloride
|
527-69-5 |
C5H3ClO2 |
详情 | 详情
|
(II) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(III) |
30751 |
2-furyl(1-piperazinyl)methanone; 2-Furoyl-1-piperazine
|
40172-95-0 |
C9H12N2O2 |
详情 | 详情
|
(IV) |
30752 |
1-piperazinyl(tetrahydro-2-furanyl)methanone; 1-(Tetrahydro-2-furoyl)piperazine
|
63074-07-7 |
C9H16N2O2 |
详情 | 详情
|
(V) |
10443 |
2-Chloro-6,7-dimethoxy-4-quinazolinamine; 4-Amino-2-chloro-6,7-dimethoxyquinazoline; 2-Chloro-6,7-dimethoxy-4-quinazolinylamine
|
23680-84-4 |
C10H10ClN3O2 |
详情 | 详情
|
合成路线19
该中间体在本合成路线中的序号:
(XI) 2) The condensation of quinoline (IX) with piperazine (XI) by heating at 140 C as before gives 1-cyclopropyl-6-fluoro-7-(1-piperazinyl)-4-oxo-1,4-dihydroquinoline-3-3-carboxylic acid (XII), which is finally treated with ethyl iodide and triethylamine in hot DMF.
【1】
Grohe, K.; Petersen, U.; Kuck, K.-H. (Bayer AG); Antimicrobial agent of quinolone-carboxylic acid b. DE 3248507; US 4563459 .
|
【2】
Grohe, K.; Klimetzek, V.; Metzger, K.G.; Stunkel, K.G.; Zeiler, H.-J. (Bayer AG); Immunostimulant agent. AU 8542762; DE 3420116; EP 0165474; ES 8607020; JP 1985258163; US 4659603 .
|
【3】
Castaner, J.; Prous, J.; Enrofloxacin. Drugs Fut 1988, 13, 4, 305.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10925 |
Iodoethane;ethyl iod |
75-03-6 |
C2H5I |
详情 | 详情
|
(IX) |
22101 |
7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
86393-33-1 |
C13H9ClFNO3 |
详情 | 详情
|
(XI) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(XII) |
22103 |
1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid
|
85721-33-1 |
C17H18FN3O3 |
详情 | 详情
|
合成路线20
该中间体在本合成路线中的序号:
(IX) This compound can be prepared by two related ways:
1) The reaction of 2-nitrobenzoic acid (I) with PCl5 at 50 C gives the corresponding acyl chloride (II), which by a Friedel-Craft's condensation with benzene and AlCl3 yields 2-nitrobenzophenone (III).
The reduction of (III) with H2 over Pd/C in ethanol affords 2-aminobenzophenone (IV), which is acylated with acetic anhydride sodium acetate to give 2-acetamidobenzophenone (V). The cyclization of (V) by means of sodium methoxide in refluxing ethanol yields 4-phenylquinoline-2(1H)-one (VI), which by reaction with SOCl2-DMF in hot CHCl3 is converted to 2-chloro-4-phenylquinoline (VII). Finally, this compound is condensed with N-ethylpiperazine (VIII) at 130 C.
2) Quinoline (VII) is condensed with piperazine (IX) as before to give 4-phenyl-2-(1-piperazinyl)quinoline (X), which is finally alkylated with ethyl iodide and sodium carbonate in refluxing butanone.
【1】
Uno, H.; Nagai, Y.; Karasawa, T.; Furukawa, K. (Dainippon Pharm. Co.; Ltd.); 2-(4-Ethyl-1-piperazinyl)-4-phenylquinoline and its salts with acids, process for their preparation and their use as antidepressant agents. DE 2912414 .
|
【2】
Uno, H.; Nagai, Y.; Hino, K.; Kawashima, K.; Oka, M.; Matsumoto, J.; A novel class of antiulcer agents. 4-Phenyl-2-(1-piperazinyl)quinolines. Chem Pharm Bull 1989, 37, 1, 110.
|
【3】
Prous, J.; Castaner, J.; AD-2646. Drugs Fut 1989, 14, 8, 735.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20951 |
2-nitrobenzoic acid;o-Nitrobenzoic acid |
552-16-9 |
C7H5NO4 |
详情 | 详情
|
(II) |
21099 |
o-nitrobenzoyl chloride; 2-nitrobenzoyl chloride
|
610-14-0 |
C7H4ClNO3 |
详情 | 详情
|
(III) |
21100 |
(2-nitrophenyl)(phenyl)methanone
|
2243-79-0 |
C13H9NO3 |
详情 | 详情
|
(IV) |
21101 |
(2-aminophenyl)(phenyl)methanone; 2-Aminobenzophenone
|
2835-77-0 |
C13H11NO |
详情 | 详情
|
(V) |
21102 |
N-(2-benzoylphenyl)acetamide
|
85-99-4 |
C15H13NO2 |
详情 | 详情
|
(VI) |
21103 |
4-phenyl-2(1H)-quinolinone
|
|
C15H11NO |
详情 |
详情
|
(VII) |
21104 |
2-chloro-4-phenylquinoline
|
|
C15H10ClN |
详情 |
详情
|
(VIII) |
14213 |
N-Ethylpiperazine; 1-Ethylpiperazine
|
5308-25-8 |
C6H14N2 |
详情 | 详情
|
(IX) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(X) |
21107 |
4-phenyl-2-(1-piperazinyl)quinoline
|
|
C19H19N3 |
详情 |
详情
|
合成路线21
该中间体在本合成路线中的序号:
(III) This compound has been obtained by two related ways:
1) The saponification of 2-(5-chloro-2-oxobenzothiazolin-3-yl)acetic acid methyl ester (I) with NaOH in methanol/water gives the corresponding free acid (II), which is condensed with piperazine (III) by means of TiCl4 in THF yielding the acyl piperazine (IV). The nitrosation of (IV) with isoamyl nitrite in dichloromethane affords the N-nitrosopiperazine (V), which is finally reduced with Zn and acetic acid to the target amino derivative.
2) The nitrosation of piperazine (III) with NaNO2 and acetic acid gives 1-nitrosopiperazine (VI), which is reduced with Zn and acetic acid to 1-aminopiperazine (VII). The reaction of (VII) with benzaldehyde affords 1-(benzylideneamino)piperazine (VIII), which is condensed with of 2-(5-chloro-2-oxobenzothiazolin-3-yl)acetic acid (II) by means of SOCl2 and triethylamine in dichloromethane yielding the acyl piperazine (IX). Finally, this compound is debenzylated with hydroxylamine and HCl in acetonitrile/water.
【1】
Matsuo, M.; Nakaguchi, O.; Okumura, H.; Tsuji, K.; Ueda, I. (Fujisawa Pharmaceutical Co., Ltd.); N-Containing fused heterocyclic cpds., processes for the preparation thereof and pharmaceutical compsn. comprising the same. EP 0232740; JP 1987181253; US 4797399 . |
【2】
Zanka, A.; et al.; Process development of a platelet aggregation inhibitor. Org Process Res Dev 1998, 2, 6, 418.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10498 |
Benzaldehyde;Benzoic aldehyde;Phenylmethanal |
100-52-7 |
C7H6O |
详情 | 详情
|
(I) |
35662 |
methyl 2-[5-chloro-2-oxo-1,3-benzothiazol-3(2H)-yl]acetate
|
|
C10H8ClNO3S |
详情 |
详情
|
(II) |
35663 |
2-[5-chloro-2-oxo-1,3-benzothiazol-3(2H)-yl]acetic acid
|
|
C9H6ClNO3S |
详情 |
详情
|
(III) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(IV) |
35664 |
5-chloro-3-[2-oxo-2-(1-piperazinyl)ethyl]-1,3-benzothiazol-2(3H)-one
|
|
C13H14ClN3O2S |
详情 |
详情
|
(V) |
35665 |
5-chloro-3-[2-(4-nitroso-1-piperazinyl)-2-oxoethyl]-1,3-benzothiazol-2(3H)-one
|
|
C13H13ClN4O3S |
详情 |
详情
|
(VI) |
17260 |
1-nitrosopiperazine
|
|
C4H9N3O |
详情 |
详情
|
(VII) |
35666 |
1-piperazinylamine; 1-piperazinamine
|
|
C4H11N3 |
详情 |
详情
|
(VIII) |
35667 |
N-[(E)-benzylidene]-N-(1-piperazinyl)amine; N-[(E)-benzylidene]-1-piperazinamine
|
|
C11H15N3 |
详情 |
详情
|
(IX) |
35668 |
5-chloro-3-[2-oxo-2-(4-[[(E)-benzylidene]amino]-1-piperazinyl)ethyl]-1,3-benzothiazol-2(3H)-one
|
|
C20H19ClN4O2S |
详情 |
详情
|
合成路线22
该中间体在本合成路线中的序号:
(XII) The cyclization of ethyl cyanoacetate (I) with urea (II) in ethanolic NaOEt provided 6-aminouracil (III). Nitrosation of (III) with NaNO2 in aqueous AcOH, followed by reduction of the resulting nitroso compound (IV) using sodium hydrosulfite gave 5,6-diaminouracil, which was purified by conversion to its hydrochloride salt (V). Condensation of this diamine with melted oxalic acid produced tetrahydroxypteridine (VI). Subsequent reaction of (VI) with PCl5 and POCl3 afforded tetrachlorocompound (VII). The reaction of (VII) with pyrrolidine (VIII) in aqueous KHCO3/CHCl3 resulted in a mixture of 2-, 4-, 7- and 4,7-substituted compounds, from which the desired 4-pyrrolidino-2,6,7-trichloropteridine (IX) was isolated by column chromatography. Further treatment of (IX) with benzylamine (X) in dioxan at r.t. provided diamine (XI). Finally, substitution of the third chlorine atom for piperazine (XII) was accomplished in boiling dioxan.
【1】
Merz, K.-H.; Marko, D.; Regiert, T.; Reiss, G.; Frank, W.; Eisenbrand, G.; Synthesis of 7-benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine and novel derivatives free of positional isomers. Potent inhibitors of cAMP-specific phosphodiesterase and of malignant tumor cell growth. J Med Chem 1998, 41, 24, 4733. |
【2】
Taylor, E.C. Jr.; Sherman, W.R.; Diaminouracil hydrochloride. Org Synth Coll 1957, 37, 15.
|
【3】
Schopf, C.; Reichert, R.; Zur kenntnis des leukopterins. Liebigs Ann Chem 1941, 548, 82.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11877 |
Cyanoacetic acid ethyl ester; Ethyl 2-cyanoacetate; Ethyl cyanoacetate; Ethyl isocyanacetate
|
105-56-6 |
C5H7NO2 |
详情 | 详情
|
(II) |
19310 |
urea
|
57-13-6 |
CH4N2O |
详情 | 详情
|
(III) |
19311 |
6-amino-2,4(1H,3H)-pyrimidinedione
|
873-83-6 |
C4H5N3O2 |
详情 | 详情
|
(IV) |
19312 |
6-amino-5-nitroso-2,4(1H,3H)-pyrimidinedione
|
|
C4H4N4O3 |
详情 |
详情
|
(V) |
19313 |
5,6-diamino-2,4(1H,3H)-pyrimidinedione
|
3240-72-0 |
C4H6N4O2 |
详情 | 详情
|
(VI) |
19314 |
2,4,6,7-pteridinetetrol
|
|
C6H4N4O4 |
详情 |
详情
|
(VII) |
19315 |
2,4,6,7-tetrachloropteridine
|
|
C6Cl4N4 |
详情 |
详情
|
(VIII) |
11376 |
Pyrrolidine
|
123-75-1 |
C4H9N |
详情 | 详情
|
(IX) |
19317 |
2,6,7-trichloro-4-(1-pyrrolidinyl)pteridine
|
|
C10H8Cl3N5 |
详情 |
详情
|
(X) |
15147 |
Benzylamine; Phenylmethanamine
|
100-46-9 |
C7H9N |
详情 | 详情
|
(XI) |
19319 |
N-benzyl-N-[2,6-dichloro-4-(1-pyrrolidinyl)-7-pteridinyl]amine; N-benzyl-2,6-dichloro-4-(1-pyrrolidinyl)-7-pteridinamine
|
|
C17H16Cl2N6 |
详情 |
详情
|
(XII) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
合成路线23
该中间体在本合成路线中的序号:
(IV) The reaction of 1-bromo-3-chloropropane (I) with thiophenol (II) by means of NaOH in refluxing water gives 1-(phenylthio)-3-chloropropane (III), which is condensed with piperazine (IV) by means of NaOH in refluxing ethanol-water yielding 1-(3-phenylthiopropyl)piperazine (V). Finally, this compound is condensed with 7-(2,3-epoxypropyl)theophylline (VI) in refluxing ethanol.
【1】
Favier, C.; Pinhas, H.; Beranger, S.; Pascal, J.-C. (Roche Bioscience); Piperazine derivatives of theophylline. EP 0033674; GB 2069487; JP 56120683; US 4374835 .
|
【2】
Castaner, R.M.; Castaner, J.; Serradell, M.N.; Tester-Dalderup, C.; Tazifylline Hydrochloride. Drugs Fut 1987, 12, 11, 1036.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12951 |
Benzenethiol; Phenylmercaptan; Phenylhydrosulfide
|
108-98-5 |
C6H6S |
详情 | 详情
|
(II) |
10358 |
1-Bromo-3-chloropropane
|
109-70-6 |
C3H6BrCl |
详情 | 详情
|
(III) |
27778 |
1-[(3-chloropropyl)sulfanyl]benzene
|
|
C9H11ClS |
详情 |
详情
|
(IV) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(V) |
27779 |
1-[3-(phenylsulfanyl)propyl]piperazine
|
|
C13H20N2S |
详情 |
详情
|
(VI) |
27780 |
1,3-dimethyl-7-(2-oxiranylmethyl)-3,7-dihydro-1H-purine-2,6-dione
|
|
C10H12N4O3 |
详情 |
详情
|
合成路线24
该中间体在本合成路线中的序号:
(VI) The cyclization of 2-(2,4-dichloro-5-fluorobenzoyl)acetic acid ethyl ester (I) with S-phenyl(cyclopropylimino)chlorothioformate (II) by means of NaH in DMF gives 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-2-(phenylsulfanyl)-1,4-dihydroquinoline-3-carboxylic acid ethyl ester (III), which is oxidized with MCPBA in dichloromethane, yielding the sulfinyl derivative (IV). The cyclization of (IV) with NaSH and hydroxylamine-O-sulfonic acid in THF affords the isothiazoloquinoline (V), which is finally condensed with piperazine in pyridine to furnish the target compound.
【1】
Mohamadi, F.; Spees, M.M.; Grindey, G.B.; Antineoplastic bicyclic sulfonylureas. Bioorg Med Chem Lett 1992, 3, 987-992.
|
【2】
Chu, D.T.W.; Isothiazoloquinolones: Antibacterial and antineoplastic agents. Drugs Fut 1992, 17, 12, 1101.
|
【3】
Ehlhardt, W.J.; Woodland, J.M.; Worzalla, J.F.; Bewley, J.R.; Grindey, G.B.; Todd, G.C.; Toth, J.E.; Howbert, J.J.; Comparison of metabolism and toxicity to the structure of the anticancer agent sulofenur and related sulfonylureas. Chem Res Toxicol 1992, 5, 5, 667. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22096 |
ethyl 3-(2,4-dichloro-5-fluorophenyl)-3-oxopropanoate
|
|
C11H9Cl2FO3 |
详情 |
详情
|
(II) |
43201 |
1-[[chloro(cyclopropylimino)methyl]sulfanyl]benzene
|
|
C10H10ClNS |
详情 |
详情
|
(III) |
43208 |
ethyl 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-2-(phenylsulfanyl)-1,4-dihydro-3-quinolinecarboxylate
|
|
C21H17ClFNO3S |
详情 |
详情
|
(IV) |
43209 |
ethyl 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-2-(phenylsulfinyl)-1,4-dihydro-3-quinolinecarboxylate
|
|
C21H17ClFNO4S |
详情 |
详情
|
(V) |
43210 |
7-chloro-9-cyclopropyl-6-fluoroisothiazolo[5,4-b]quinoline-3,4(2H,9H)-dione
|
|
C13H8ClFN2O2S |
详情 |
详情
|
(VI) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
合成路线25
该中间体在本合成路线中的序号:
(X) The condensation of 2-(2,4,5-trifluorobenzoyl)acetic acid ethyl ester (I) with cyclopropyl isothiocyanate (II) by means of NaH in DMF gives the sodium salt (IIIa-b), which is methylated with methyl iodide to afford the methylsulfanyl derivative (IVa-b). The cyclization of (IVa-b) by means of NaH in THF provides the methylsulfanyl quinolone (V), which is oxidized with MCPBA to the corresponding methylsulfinyl compound (VI). The reaction of (VI) with NaSH in THF furnishes 1-cyclopropyl-6,7-difluoro-4-oxo-2-sulfanyl-1,4-dihydroquinoline-3-carboxylic acid ethyl ester (VII), which is cyclized with hydroxylamine-O-sulfonic acid and NaHCO3 through the intermediate (VIII), affording the isothiazoloquinoline (IX). Finally, this compound is condensed with piperazine (X) in pyridine to give the target compound.
【1】
Chu, D.T.W.; Isothiazoloquinolones: Antibacterial and antineoplastic agents. Drugs Fut 1992, 17, 12, 1101.
|
【2】
Aquilar-Bryan, L.; Bryan, J.; Boyd, A.E. III; et al.; Sulfonylurea signal transduction. Recent Prog Horm Res 1991, 47, 299-317.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IIIa) |
43212 |
sodium (Z)-1-(cyclopropylamino)-3-ethoxy-3-oxo-2-(2,4,5-trifluorobenzoyl)-1-propene-1-thiolate
|
|
C15H13F3NNaO3S |
详情 |
详情
|
(IIIb) |
43213 |
sodium (E)-1-(cyclopropylamino)-3-ethoxy-3-oxo-2-(2,4,5-trifluorobenzoyl)-1-propene-1-thiolate
|
|
C15H13F3NNaO3S |
详情 |
详情
|
(IVa) |
43214 |
ethyl (Z)-3-(cyclopropylamino)-3-(methylsulfanyl)-2-(2,4,5-trifluorobenzoyl)-2-propenoate
|
|
C16H16F3NO3S |
详情 |
详情
|
(IVb) |
43215 |
ethyl (E)-3-(cyclopropylamino)-3-(methylsulfanyl)-2-(2,4,5-trifluorobenzoyl)-2-propenoate
|
|
C16H16F3NO3S |
详情 |
详情
|
(I) |
22096 |
ethyl 3-(2,4-dichloro-5-fluorophenyl)-3-oxopropanoate
|
|
C11H9Cl2FO3 |
详情 |
详情
|
(II) |
43211 |
1-isothiocyanatocyclopropane; cyclopropyl isothiocyanate
|
56601-42-4 |
C4H5NS |
详情 | 详情
|
(V) |
43216 |
ethyl 1-cyclopropyl-6,7-difluoro-2-(methylsulfanyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C16H15F2NO3S |
详情 |
详情
|
(VI) |
43217 |
ethyl 1-cyclopropyl-6,7-difluoro-2-(methylsulfinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C16H15F2NO4S |
详情 |
详情
|
(VII) |
43218 |
ethyl 1-cyclopropyl-6,7-difluoro-4-oxo-2-sulfanyl-1,4-dihydro-3-quinolinecarboxylate
|
|
C15H13F2NO3S |
详情 |
详情
|
(VIII) |
43219 |
ethyl 2-(aminosulfanyl)-1-cyclopropyl-6,7-difluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C15H14F2N2O3S |
详情 |
详情
|
(IX) |
43220 |
9-cyclopropyl-6,7-difluoroisothiazolo[5,4-b]quinoline-3,4(2H,9H)-dione
|
|
C13H8F2N2O2S |
详情 |
详情
|
(X) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
合成路线26
该中间体在本合成路线中的序号:
(IV) The synthesis has been described by Bøgesø et al. and the absolute configuration has been determined by X-ray crystallography by Jensen.
【1】
Hyttel, J.; Bogeso, K.P.; Gundertofte, K.; Boeck, V.; Christensen, A.V.; Arnt, J.; Antihypertensive activity in a series of 1-piperazino-3-phenylindans with potent 5-HT2-antagonistic activity. J Med Chem 1988, 31, 12, 2247.
|
【2】
Jensen, B.; Structure of the (+)-tartrate of the selective 5-HT2 antagonist irindalon. Acta Cryst 1988, C44, 1602.
|
【3】
Boeck, V.; Bogeso, K.P.; Hyttel, J.; IRINDALONE TARTRATE < Rec INNM >. Drugs Fut 1989, 14, 9, 859.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
21325 |
1-chloro-3-(4-fluorophenyl)indane
|
|
C15H12ClF |
详情 |
详情
|
(II) |
21326 |
1-[3-(4-fluorophenyl)-2,3-dihydro-1H-inden-1-yl]piperazine
|
|
C19H21FN2 |
详情 |
详情
|
(III) |
21327 |
1-(2-[4-[3-(4-fluorophenyl)-2,3-dihydro-1H-inden-1-yl]-1-piperazinyl]ethyl)-2-imidazolidinone
|
|
C24H29FN4O |
详情 |
详情
|
(IV) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(V) |
21329 |
1-(2-chloroethyl)-2-imidazolidinone
|
2387-20-4 |
C5H9ClN2O |
详情 | 详情
|
合成路线27
该中间体在本合成路线中的序号:
(IX) The reaction of 3,4-difluoroaniline (I) with carbon disulfide and triethylamine gives triethylammonium N-(3,4-difluorophenyl)dithiocarbamate (II), which by reaction with ethyl chloroformate and triethylamine in chloroform is converted into 3,4-difluorophenyl isothiocyanate (III). The reaction of (III) with diethyl malonate and KOH in dioxane affords the potassium salt (IV), which is treated with chloromethyl methyl ether in DMF to give the corresponding methoxymethylsulfanyl compound (V). The cyclization of (V) at 240 C in diphenyl ether affords 6,7-difluoro-4-hydroxy-2-(methoxymethylsulfanyl)quinoline-3-carboxylic acid ethyl ester (VI), which by treatment with HCl in ethanol gives the corresponding mercapto compound (VII). The cyclization of (VII) with 1,1-dibromoethane by means of K2CO3 and KI in hot DMF yields 5,6-difluoro-1-methyl-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid ethyl ester (VIII), which is condensed with piperazine (IX) in DMF to afford the corresponding piperazino-derivative (X). The hydrolysis of (X) with KOH in hot tert-butanol gives the corresponding free acid (XI) , which is finally condensed with 4-(bromomethyl)-5-methyl-1,3-dioxol-2-one (XII) by means of KHCO3 in DMF.
【1】
Tracy, M.; Castaner, J.; Prulifloxazin < Prop INN >. Drugs Fut 1996, 21, 8, 805.
|
【2】
Kise, M.; Kitano, M.; Ozaki, M.; Kazuno, K.; Matsuda, M.; Shirahase, I.; Segawa, J. (Nippon Shinyaku Co., Ltd.); Quinolinecarboxylic acid derivs. AU 8824673; EP 0315828; JP 1989294680 .
|
【3】
Segawa, J.; Kitano, M.; Kazuno, K.; Matsuoka, M.; Shirahase, I.; Ozaki, M.; Matsuda, M.; Tomii, Y.; Kise, M.; Studies on pyridonecarboxylic acids. 1. Synthesis and antibacterial evaluation of 7-substituted-6-halo-4-oxo-4H-[1,3]thiazeto[3, 2-a]quinoline-3-carboxylic acids. J Med Chem 1992, 35, 25, 4727. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13451 |
3,4-Difluoroaniline; 3,4-Difluorophenylamine
|
3863-11-4 |
C6H5F2N |
详情 | 详情
|
(II) |
13452 |
N,N-diethyl-1-ethanaminium 3,4-difluorophenylcarbamodithioate
|
|
C13H20F2N2S2 |
详情 |
详情
|
(III) |
13453 |
1,2-Difluoro-4-isothiocyanatobenzene; 3,4-difluorophenyl isothiocyanate
|
113028-75-4 |
C7H3F2NS |
详情 | 详情
|
(IV) |
13454 |
2-(3,4-Difluorophenylamino)-2-sulfanylethylene-1,1-dicarboxylic acid diethyl ester potassium salt
|
|
C14H14F2KNO4S |
详情 |
详情
|
(V) |
13455 |
diethyl 2-[(3,4-difluoroanilino)[(methoxymethyl)sulfanyl]methylene]malonate
|
|
C16H19F2NO5S |
详情 |
详情
|
(VI) |
13456 |
ethyl 6,7-difluoro-4-hydroxy-2-[(methoxymethyl)sulfanyl]-3-quinolinecarboxylate
|
|
C14H13F2NO4S |
详情 |
详情
|
(VII) |
13457 |
ethyl 6,7-difluoro-4-hydroxy-2-sulfanyl-3-quinolinecarboxylate
|
|
C12H9F2NO3S |
详情 |
详情
|
(VIII) |
13458 |
ethyl 6,7-difluoro-1-methyl-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C14H11F2NO3S |
详情 |
详情
|
(IX) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(X) |
13460 |
ethyl 6-fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C18H20FN3O3S |
详情 |
详情
|
(XI) |
13461 |
6-Fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid
|
|
C16H16FN3O3S |
详情 |
详情
|
(XII) |
13462 |
4-(Bromomethyl)-5-methyl-1,3-dioxol-2-one
|
80715-22-6 |
C5H5BrO3 |
详情 | 详情
|
合成路线28
该中间体在本合成路线中的序号:
(VI) The cyclization of 3-(2,6-dichloro-5-fluoropyridin-3-yl)-3-oxopropionic acid ethyl ester (I) with S-phenyl(cyclopropylimino)chlorothioformate (II) by means of NaH in DMF gives 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-2-(phenylsulfanyl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid ethyl ester (III), which is oxidized with MCPBA in dichloromethane, yielding the sulfinyl derivative (IV). The cyclization of (IV) with NaSH and hydroxylamine-O-sulfonic acid in THF affords the isothiazolonaphthyridine (V), which is finally condensed with piperazine in pyridine to furnish the target compound.
【1】
Aquilar-Bryan, L.; Bryan, J.; Boyd, A.E. III; et al.; Sulfonylurea signal transduction. Recent Prog Horm Res 1991, 47, 299-317.
|
【2】
Chu, D.T.W.; Isothiazoloquinolones: Antibacterial and antineoplastic agents. Drugs Fut 1992, 17, 12, 1101.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15228 |
ethyl 3-(2,6-dichloro-5-fluoro-3-pyridinyl)-3-oxopropanoate
|
|
C10H8Cl2FNO3 |
详情 |
详情
|
(II) |
43201 |
1-[[chloro(cyclopropylimino)methyl]sulfanyl]benzene
|
|
C10H10ClNS |
详情 |
详情
|
(III) |
43205 |
ethyl 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-2-(phenylsulfanyl)-1,4-dihydro[1,8]naphthyridine-3-carboxylate
|
|
C20H16ClFN2O3S |
详情 |
详情
|
(IV) |
42306 |
methyl 4-[5-(1,5-diisopropyl-1H-pyrazol-3-yl)-1H-pyrrol-2-yl]benzoate
|
|
C21H25N3O2 |
详情 |
详情
|
(V) |
43027 |
tert-butyl (1S)-1-isobutyl-3-methyl-2-oxo-3-butenylcarbamate
|
|
C14H25NO3 |
详情 |
详情
|
(VI) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
合成路线29
该中间体在本合成路线中的序号:
(V) This compound can be obtained by two related ways:
1) The reaction of cis-octahydroisobenzofuran-1,3-dione (I) with ammonia in water at 180-90 gives cis-octahydro-1H-isoindole-1,3-dione (II), which is alkylated with 1,4-dibromobutane (III) and K2CO3 in refluxing acetone to yield cis-2-(4-bromobutyl)octahydro-1H-isoindole-1,3-dione (IV). The condensation of (IV) with piperazine (V) in refluxing toluene affords cis-2-(4-piperazinobutyl)octahydro-1H-isoindole-1,3-dione (VI), which is finally condensed with 3-chloro-1,2-benzisothiazole (VII) and K2CO3 in refluxing toluene.
2) The condensation of benzisothiazole (VII) with piperazine (V) by heating at 120 C gives 3-piperazino-1,2-benzisothiazole (VIII), which is then condensed with isoindole (IV) by means of K2CO3 and KI in hot DMF.
3) The 3-chloro-1,2-benzisothiazole (VII) is obtained as follows: The reaction of 2,2'-dithiobenzoic acid (IX) with refluxing SOCl2 gives the corresponding acyl chloride (X), which by treatment with methylamine in THF is converted into the diamide (XI). The reaction of (XI) with PCl5 in refluxing benzene affords 3-chloro-2-methyl-1,2-benzisothiazolium chloride (XII), which is finally heated in refluxing 1,2-dichlorobenzene to give (VII).
【1】
Ishizumi, N.; Antoku, F.; Maruyama, I.; Kojima, A. (Sumitomo Pharmaceuticals Co., Ltd.); Imide derivs., their production and use. EP 0196096; ES 8800219; JP 1987123179; JP 1987277355; JP 1987277356; US 4745117 .
|
【2】
Prous, J.; Castaner, J.; SM-9018. Drugs Fut 1991, 16, 2, 122.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
27329 |
(3aR,7aS)hexahydro-2-benzofuran-1,3-dione
|
13149-00-3 |
C8H10O3 |
详情 | 详情
|
(II) |
31245 |
(3aR,7aS)hexahydro-1H-isoindole-1,3(2H)-dione
|
7506-66-3 |
C8H11NO2 |
详情 | 详情
|
(III) |
11883 |
1,4-Dibromobutane; 1,4-Butylene bromide
|
110-52-1 |
C4H8Br2 |
详情 | 详情
|
(IV) |
31246 |
(3aR,7aS)-2-(4-bromobutyl)hexahydro-1H-isoindole-1,3(2H)-dione
|
|
C12H18BrNO2 |
详情 |
详情
|
(V) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(VI) |
31247 |
(3aR,7aS)-2-[4-(1-piperazinyl)butyl]hexahydro-1H-isoindole-1,3(2H)-dione
|
|
C16H27N3O2 |
详情 |
详情
|
(VII) |
16279 |
3-chloro-1,2-benzisothiazole
|
|
C7H4ClNS |
详情 |
详情
|
(VIII) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
(IX) |
20404 |
2-[(2-carboxyphenyl)disulfanyl]benzoic acid; 2,2'-Dithiodibenzoic acid
|
119-80-2 |
C14H10O4S2 |
详情 | 详情
|
(X) |
20405 |
2-[[2-(chlorocarbonyl)phenyl]disulfanyl]benzoyl chloride
|
|
C14H8Cl2O2S2 |
详情 |
详情
|
(XI) |
31248 |
N-methyl-2-([2-[(methylamino)carbonyl]phenyl]disulfanyl)benzamide
|
2527-58-4 |
C16H16N2O2S2 |
详情 | 详情
|
(XII) |
31249 |
3-chloro-2-methyl-1,2-benzisothiazol-2-ium chloride
|
|
C8H7Cl2NS |
详情 |
详情
|
合成路线30
该中间体在本合成路线中的序号:
(B) FG5803 is obtained in a three-step synthesis:
In the first step 4-(4-fluorophenyl)-4,4-ethylenedioxybutylchloride (A) reacts with piperazine (B) to give 1-[4-(4-fluorophenyl)-4,4-ethylenedioxybutyl]piperazine (I), which is reacted with cyclohexylisocyanate (C) to form 4-[4-(4-fluorophenyl)-4,4-ethylenedioxybutyl]-N-cyclohexyl-1-piperazinecarboxamide (II). The protecting group is removed by HCl in ethanol and the final product is isolated, 4-[4-(4-fluorophenyl)-4-oxobutyl]-N-cyclohexyl-1-piperazinecarboxamide hydrochloride (III).
【1】
Bjork, A.; Fex, T.; Olsson, K.; Abramo, A.; Gustafsson, B.; Christensson, E. (Ferrosan AB); Novel 1-piperazinecarboxamide derivs.. EP 0136274; ES 8704917; ES 8705411; ES 8802039; JP 1985501956; US 4935419; WO 8500811 .
|
【2】
Lundstedt, T.; Bjork, A.; Pettersson, G.; Svartengren, J.; Christensson, E.; Gustavsson, B.; FG5803. Drugs Fut 1990, 15, 12, 1176.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(A) |
28203 |
2-(3-chloropropyl)-2-(4-fluorophenyl)-1,3-dioxolane
|
3308-94-9 |
C12H14ClFO2 |
详情 | 详情
|
(I) |
31226 |
1-[3-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]propyl]piperazine
|
|
C16H23FN2O2 |
详情 |
详情
|
(II) |
31227 |
N-cyclohexyl-4-[3-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]propyl]-1-piperazinecarboxamide
|
|
C23H34FN3O3 |
详情 |
详情
|
(C) |
18108 |
1-isocyanatocyclohexane; cyclohexyl isocyanate
|
3173-53-3 |
C7H11NO |
详情 | 详情
|
合成路线31
该中间体在本合成路线中的序号:
(IV) The benzoxazinorifamycin (III) was obtained by oxidative condensation of rifamycin S (I) with 2-aminoresorcinol (II). 1-Isobutylpiperazine (V), prepared by alkylation of piperazine (IV) with isobutyl bromide, was then coupled to the benzoxazine ring of (III) in the presence of MnO2 as the oxidant to afford the target piperazinyl derivative.
In an improved procedure, 2-aminoresorcinol (II) was protected as the mono-silyl ether (VI) and subsequently coupled to rifamycin S (I) in the presence of MnO2, yielding (VII). Oxidative coupling of the benzoxazino derivative (VII) with 1-isobutylpiperazine (V) proceeded with simultaneous desilylation to furnish the title compound.
【1】
Yamane, T.; Hashizume, T.; Yamashita, K.; Hosoe, K.; Kuze, F.; Watanabe, K. (Kaneka Corp.); 3'-Hydroxybenzoxazinorifamycin deriv., process for preparing the same and antibacterial agent containing them. EP 0366914; JP 1991007291; US 4983602 .
|
【2】
Yamane, T.; et al.; Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives. Chem Pharm Bull 1993, 41, 1, 148.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
58522 |
(7S,11S,12R,13S,14R,15R,16R,17S,18S)-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18-hexamethyl-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo[23.3.1.1~4,7~.0~5,28~]triaconta-1(28),2,4,9,19,21,25-heptaen-13-yl acetate
|
|
C36H43NO12 |
详情 |
详情
|
(II) |
58101 |
2-amino-1,3-benzenediol
|
|
C6H7NO2 |
详情 |
详情
|
(III) |
58523 |
(7S,11S,12R,13S,14R,15R,16R,17S,18S)-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18-hexamethyl-6,23,37-trioxo-8,27,38-trioxa-24,34-diazahexacyclo[23.11.1.1~4,7~.0~5,36~.0~26,35~.0~28,33~]octatriaconta-1(36),2,4,9,19,21,25,28,30,32,34-undecaen-13-yl acetate |
|
C42H46N2O13 |
详情 |
详情
|
(IV) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(V) |
58524 |
N-Isobutyl piperazine
|
5308-28-1 |
C8H18N2 |
详情 | 详情
|
(VI) |
58102 |
2-amino-3-{[tert-butyl(dimethyl)silyl]oxy}phenol
|
|
C12H21NO2Si |
详情 |
详情
|
(VII) |
58525 |
(7S,11S,12R,13S,14R,15R,16R,17S,18S)-32-{[tert-butyl(dimethyl)silyl]oxy}-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18-hexamethyl-6,23,37-trioxo-8,27,38-trioxa-24,34-diazahexacyclo[23.11.1.1~4,7~.0~5,36~.0~26,35~.0~28,33~]octatriaconta-1(36),2,4,9,19,21,25,28,30,32,34-undecaen-13-yl acetate |
|
C48H60N2O13Si |
详情 |
详情
|
合成路线32
该中间体在本合成路线中的序号:
(II) The title compound was obtained by condensation between 2-fluoro-5-methylbenzenesulfonic acid (I) and piperazine (II) in the presence of copper powder and cuprous iodide in a sealed tube at 160 C. It was converted to the more stable monohydrate form by suspension of the anhydrous crystals in cold water.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
59240 |
2-fluoro-5-methylbenzenesulfonic acid
|
|
C7H7FO3S |
详情 |
详情
|
(II) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
合成路线33
该中间体在本合成路线中的序号:
(II) By condensation of 2-chloro-4-(2-fluorophenyl)-6-methylthieno[2,3-d]pyrimidine (I) with piperazine (II) in refluxing chloroform or ethanol.
【1】
Ninomiya, K.; Nitta, I.; Tobe, A.; Egawa, S. (Mitsubishi Chem. Ind., Ltd.); Antidepressant and cerebral function improving agents. JP 8700042 .
|
【2】
Ninomiya, K.; Nitta, I.; Tobe, A.; Egawa, M.; Kikumoto, R. (Mitsubishi Chemical Corp.); Thieno[2,3-d]pyrimidine derivs. And salts thereof. EP 0150469; JP 1985146891 .
|
【3】
Ninomiya, K.; Nitta, K.; Tobe, A.; Egawa, M. (Mitsubishi Chemical Corp.); Antidepressant and cerebral function improving agent. JP 1987000427 .
|
【4】
Prous, J.; Castaner, J.; MCI-225. Drugs Fut 1992, 17, 5, 380.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14760 |
2-chloro-4-(2-fluorophenyl)-6-methylthieno[2,3-d]pyrimidine
|
|
C13H8ClFN2S |
详情 |
详情
|
(II) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
合成路线34
该中间体在本合成路线中的序号:
(II) The preparation of KW-3196 is as follows: Reaction of 1,4:3,6-dianhydro-D-glucitol 5-methanesulfonate (I) (1) with piperazine (II) afforded (III), which was nitrated with fuming HNO3 to give the nitrate ester (IV). Nicotynoylation of (IV) gave KW-319).
【1】
Klessing, K.; Chatterjee, S.S. (Dr. Willmar Schwabe); Alkylaminodeoxy-1,4:3,6-dianhydrohexitol nitrates substituted by purine bases and their pharmaceutical compositions. EP 0044927 .
|
【2】
Suzuki, F.; Hayashi, H.; Kuroda, T.; Kubo, K.; Ikeda, J. (Kyowa Hakko Kogyo Co., Ltd.); Hexitol derivatives having vasodilative activity. EP 0393574; JP 1991218381; US 5053408 .
|
【3】
Ueno, H.; Hayashi, H.; Suzuki, F.; Synthesis of stereoisomers of 1,4:3,6-dianhydrohexitol nitrate derivative, KF14124. Bioorg Med Chem Lett 1992, 2, 1187-92.
|
【4】
Suzuki, F.; KW-3196. Drugs Fut 1992, 17, 11, 995.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14844 |
(3R,3aS,6S,6aR)-6-hydroxyhexahydrofuro[3,2-b]furan-3-yl methanesulfonate
|
|
C7H12O6S |
详情 |
详情
|
(II) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(III) |
14845 |
(3S,3aR,6S,6aR)-6-piperazinohexahydrofuro[3,2-b]furan-3-ol
|
|
C10H18N2O3 |
详情 |
详情
|
(IV) |
14846 |
1-[(3S,3aR,6S,6aS)-6-(nitrooxy)hexahydrofuro[3,2-b]furan-3-yl]piperazine
|
|
C10H17N3O5 |
详情 |
详情
|
(V) |
10753 |
Nicotinoyl chloride
|
|
C6H4ClNO |
详情 |
详情
|
合成路线35
该中间体在本合成路线中的序号:
(I) Nucleophilic aromatic substitution of 2-chloro-3-nitropyridine (II) with excess piperazine (I) in acetonitrile at room temperature produces 1-(3-nitro-2-pyridyl)piperazine. Protection of the free piperazine nitrogen by treatment with di-tert-butyldicarbonate affords nitropyridine (III). Reduction of the nitro group to the amine is accomplished via hydrogenation (40 psi) over palladium on carbon. Treatment of the aminopyridine with acetaldehyde and sodium cyanoborohydride in methanol affords the (ethylamino)pyridine (IV). Removal of the BOC protecting group with trifluoroacetic acid and coupling of the resulting 1-[3-(ethylamino)pyridyl]piperazine with 5-methoxyindole-2-carboxylic acid using 1-ethyl-3-(dimethylaminopropyl)carbodiimide (EDC) or 1,1'-carbonyldiimidazole (CDI) affords U-87201 (V). Dissolution of (V) in methanol, treatment with 1 eq of methanesulfonic acid, and the addition of diethyl ether results in the precipitation of atevirdine mesylate.
【1】
Richman, D.D.; Fischl, M.A.; Grieco, M.H.; et al.; The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: A double-blind, placebo-controlled trial. New Engl J Med 1987, 317, 4, 192-7.
|
【2】
Tan, C.-K.; Busso, M.; Romero, D.L.; et al.; Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication. Proc Natl Acad Sci USA 1991, 88, 19, 8806-10.
|
【3】
Romero, D.L.; Atevirdine Mesylate. Drugs Fut 1994, 19, 1, 9.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(II) |
10321 |
2-Chloro-3-nitropyridine
|
5470-18-8 |
C5H3ClN2O2 |
详情 | 详情
|
(III) |
16159 |
tert-butyl 4-(3-nitro-2-pyridinyl)tetrahydro-1(2H)-pyrazinecarboxylate
|
|
C14H20N4O4 |
详情 |
详情
|
(IV) |
14880 |
tert-butyl 4-[3-(ethylamino)-2-pyridinyl]tetrahydro-1(2H)-pyrazinecarboxylate
|
|
C16H26N4O2 |
详情 |
详情
|
(V) |
63849 |
{4-[3-(ethylamino)-2-pyridinyl]-1-piperazinyl}(1H-indol-2-yl)methanone
|
|
C20H23N5O |
详情 |
详情
|
合成路线36
该中间体在本合成路线中的序号:
(V) The reaction of 3-amino-2-chloropyridine (I) with triethyl orthoacetate (II) catalyzed by TsOH gives the acetimidate (III), which is reduced to 3-(ethylamino)-2-chloropyridine (IV) by means of DIBAL in toluene. The reaction of (IV) with piperazine (V) by means of Na2CO3 by heating at 144 C affords 3-(ethylamino)-2-(1-piperazinyl)pyridine (VI), which is finally condensed with 5-methoxy-1H-indole-2-carboxylic acid (II) by means of CDI in dichloromethane and treated with CH3SO3H in methanol to provide the target mesylate.
【1】
Perrault, W.R.; et al.; Production scale synthesis of the non-nucleoside recverse transcriptase inhibitor atervirdine mesylate (U-87,201E). Org Process Res Dev 1997, 1, 2, 106.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11160 |
2-Chloro-3-pyridinamine; 2-Chloro-3-pyridinylamine; 3-Amino-2-chloropyridine; 2-Chloro-3-aminopyridine
|
6298-19-7 |
C5H5ClN2 |
详情 | 详情
|
(II) |
36531 |
1,1,1-trimethoxypropane; 1,1-dimethoxypropyl methyl ether
|
|
C6H14O3 |
详情 |
详情
|
(III) |
36532 |
methyl N-(2-chloro-3-pyridinyl)ethanimidoate
|
|
C8H9ClN2O |
详情 |
详情
|
(IV) |
36533 |
N-(2-chloro-3-pyridinyl)-N-ethylamine; 2-chloro-N-ethyl-3-pyridinamine
|
|
C7H9ClN2 |
详情 |
详情
|
(V) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(VI) |
36534 |
N-ethyl-N-[2-(1-piperazinyl)-3-pyridinyl]amine; N-ethyl-2-(1-piperazinyl)-3-pyridinamine
|
|
C11H18N4 |
详情 |
详情
|
(VII) |
28885 |
5-methoxy-1H-indole-2-carboxylic acid
|
4382-54-1 |
C10H9NO3 |
详情 | 详情
|
合成路线37
该中间体在本合成路线中的序号:
(VI) The cyclization of 2-(2,4-dichloro-3,5-difluorobenzoyl)acetic acid ethyl ester (I) with S-phenyl(cyclopropylimino)chlorothioformate (II) by means of NaH in DMF gives 7-chloro-1-cyclopropyl-6,8-difluoro-4-oxo-2-(phenylsulfanyl)-1,4-dihydroquinoline-3-carboxylic acid ethyl ester (III), which is oxidized with MCPBA in dichloromethane, yielding the sulfinyl derivative (IV). The cyclization of (IV) with NaSH and hydroxylamine-O-sulfonic acid in THF affords the isothiazoloquinoline (V), which is finally condensed with piperazine in pyridine to furnish the target compound.
【1】
Aquilar-Bryan, L.; Bryan, J.; Boyd, A.E. III; et al.; Sulfonylurea signal transduction. Recent Prog Horm Res 1991, 47, 299-317.
|
【2】
Chu, D.T.W.; Isothiazoloquinolones: Antibacterial and antineoplastic agents. Drugs Fut 1992, 17, 12, 1101.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
43200 |
ethyl 3-(2,4-dichloro-3,5-difluorophenyl)-3-oxopropanoate
|
|
C11H8Cl2F2O3 |
详情 |
详情
|
(II) |
43201 |
1-[[chloro(cyclopropylimino)methyl]sulfanyl]benzene
|
|
C10H10ClNS |
详情 |
详情
|
(III) |
43202 |
ethyl 7-chloro-1-cyclopropyl-6,8-difluoro-4-oxo-2-(phenylsulfanyl)-1,4-dihydro-3-quinolinecarboxylate
|
|
C21H16ClF2NO3S |
详情 |
详情
|
(IV) |
43203 |
ethyl 7-chloro-1-cyclopropyl-6,8-difluoro-4-oxo-2-(phenylsulfinyl)-1,4-dihydro-3-quinolinecarboxylate
|
|
C21H16ClF2NO4S |
详情 |
详情
|
(V) |
43204 |
7-chloro-9-cyclopropyl-6,8-difluoroisothiazolo[5,4-b]quinoline-3,4(2H,9H)-dione
|
|
C13H7ClF2N2O2S |
详情 |
详情
|
(VI) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
合成路线38
该中间体在本合成路线中的序号:
(V) The synthesis of some metabolites of olanzapine have been described:
1) Synthesis of 4'-N-desmethyl olanzapine: The condensation of 2-fluoronitrobenzene (I) with 5-methylthiophene-2-amine (II) by means of LiOH in DMSO gives the expected secondary amine (III), which is cyclized by means of SnCl2 in ethanol yielding 2-methyl-10H-thieno[2,3-b][1,5]benzodiazepine-4-amine (IV). Finally, this compound is condensed with piperazine (V) in toluene/DMSO affording the metabolite 2-methyl-4-(1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine.
【1】
Calligaro, D.O.; Moore, N.A.; Tupper, D.E.; Fairhurst, J.; Hotten, T.M.; The synthesis and biological activity of some known and putative metabolites of the atypical antipsychotic agent olanzapine (LY170053). Bioorg Med Chem Lett 1997, 7, 1, 25.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13463 |
o-Fluoronitrobenzene; 1-fluoro-2-nitrobenzene
|
1493-27-2 |
C6H4FNO2 |
详情 | 详情
|
(II) |
15249 |
5-Amino-4-cyano-2-methylthiophene; 2-amino-5-methyl-3-thiophenecarbonitrile
|
138564-58-6 |
C6H6N2S |
详情 | 详情
|
(III) |
15250 |
5-methyl-2-(2-nitroanilino)-3-thiophenecarbonitrile
|
|
C12H9N3O2S |
详情 |
详情
|
(IV) |
15255 |
2-methyl-10H-thieno[2,3-b][1,5]benzodiazepin-4-ylamine; 2-methyl-10H-thieno[2,3-b][1,5]benzodiazepin-4-amine
|
|
C12H11N3S |
详情 |
详情
|
(V) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
合成路线39
该中间体在本合成路线中的序号:
(IV) N-Alkylation of 2-chlorobenzimidazole (I) with benzyl bromide (II) by means of NaH in DMF provides benzylated derivative (III), which is converted into the desired compound by heating with piperazine (IV).
【1】
Parihar, H.S.; et al.; 5-HT3R binding of lerisetron: An interdisciplinary approach to drug-receptor interactions. Bioorg Med Chem Lett 2001, 11, 16, 2133.
|
【2】
Orjales, A.; et al.; New 2-piperazinylbenzimidazole derivatives as 5-HT3 antagonists. Synthesis and pharmacological evaluation. J Med Chem 1997, 40, 4, 586.
|
【3】
Orjales-Venero, A.; Garcia-Dominguez, N.; Rubio-Royo, V.; Rodes-Solanes, R. (FAES); New 2-piperazinylbenzimidazole derivs.. EP 0512939; JP 1995002795; US 5256665 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26761 |
2-chloroimidazo[1,2-a]pyridine; 2-chlorobenzimidazole; 2-Amino-4'-chlorodiphenylether; 2-Aminodiphenylether; 2-chloro-1H-benzimidazole
|
4857-06-1 |
C7H5ClN2 |
详情 | 详情
|
(II) |
12912 |
1-(Bromomethyl)benzene; Alpha-bromotoluene
|
100-39-0 |
C7H7Br |
详情 | 详情
|
(III) |
49687 |
1-Benzyl-2-chloro-1H-benzoimidazole
|
|
C14H11ClN2 |
详情 |
详情
|
(IV) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
合成路线40
该中间体在本合成路线中的序号:
(I) The synthesis of delavirdine mesylate is depicted in Scheme 19654001a:
The first three chemical steps are the same as those used for the synthesis of atevirdine mesylate (ATV, U-87201E) (2, 3). Nucleophilic aromatic substitution of 2-chloro-3-nitropyridine (II) with excess piperazine in acetonitrile at room temperature produces 1-(3-nitro-2-pyridyl)piperazine. Protection of the free piperazine nitrogen by treatment with di-tert-butyldicarbonate affords nitropyridine (III). Reduction of the nitro group to the amine is accomplished via hydrogenation (40 psi) over palladium on carbon.
Treatment of the aminopyridine with acetone and sodium cyanoborohydride in methanol affords the 3-(1-methylethylamino)pyridine (IV). Removal of the BOC protecting group with trifluoroacetic acid and coupling of the resulting 1-[3-(1-methylethylamino)pyridyl]piperazine with 5-nitroindole-2-carboxylic acid using 1-ethyl-3-(dimethylaminopropyl)carbodiimide (EDC) or 1,1'-carbonyldiimidazole (CDI) affords (V). Catalytic reduction of the nitro group and treatment of the resulting amine with methanesulfonyl chloride provides U-90152. Dissolution of U-90152 in acetonitrile and treatment with 1 eq of methanesulfonic acid results in the precipitation of delavirdine mesylate.
【1】
Romero, D.L.; Atevirdine mesylate (U-87201E). Drugs Fut 1994, 19, 1, 7-12.
|
【2】
Aristoff, P.A.; Romero, D.L.; Palmer, J.R.; Thomas, R.C.; Smith, H.W. (Pharmacia Corp.); Diaromatic substd. cpds. as anti-HIV-1 agents. US 5563142 .
|
【3】
Busso, M.; Romero, D.L.; Biles, C.; Genin, M.J.; Tarpley, W.G.; Morge, R.A.; Reusser, F.; Althaus, I.W.; Thomas, R.C.; Resnick, L.; Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: Structure-activity relationships of novel substituted indole analogues and the identification oF (U-90152S), a second-generation clinical candidate. J Med Chem 1993, 36, 10, 1505-8. |
【4】
Romero, D.L.; Delavirdine Mesylate. Drugs Fut 1994, 19, 3, 238.
|
【5】
Tan, C.-K.; Busso, M.; Romero, D.L.; et al.; Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication. Proc Natl Acad Sci USA 1991, 88, 19, 8806-10.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(II) |
10321 |
2-Chloro-3-nitropyridine
|
5470-18-8 |
C5H3ClN2O2 |
详情 | 详情
|
(III) |
16159 |
tert-butyl 4-(3-nitro-2-pyridinyl)tetrahydro-1(2H)-pyrazinecarboxylate
|
|
C14H20N4O4 |
详情 |
详情
|
(IV) |
16160 |
tert-butyl 4-[3-(isopropylamino)-2-pyridinyl]tetrahydro-1(2H)-pyrazinecarboxylate
|
|
C17H28N4O2 |
详情 |
详情
|
(V) |
16161 |
[4-[3-(isopropylamino)-2-pyridinyl]piperazino](5-nitro-1H-indol-2-yl)methanone
|
|
C21H24N6O3 |
详情 |
详情
|
合成路线41
该中间体在本合成路线中的序号:
Wolff-Kishner reduction of 6-chloroisatin (I) gives 6-chlorooxindole (II), which is treated with chloroacetyl chloride under Friedel-Crafts conditions to yield 5-chloroacetyl-6-chlorooxindole (III). The ketone (III) is reduced using triethylsilane in trifluoroacetic acid to produce 6-chloro-5-(2-chloroethyl)oxindole (IV). 1,2-Benzisothiazolin-3-one (V) is converted to 3-chloro-1,2-benzisothiazole (VI) using phosphorus oxychloride and is then condensed with piperazine to provide 1-(1,2-benzisothiazol-3-yl)piperazine (VII). Finally, intermediate (VII) is alkylated by compound (IV) in the presence of sodium carbonate in water and is converted to the salt with aqueous hydrochloric acid.
【1】
Lowe, J.A. III; Nagel, A.A. (Pfizer Inc.); Piperazinyl-heterocyclic cpds. US 4831031 .
|
【2】
Bowles, P. (Pfizer Inc.); Process for preparing aryl piperazinyl-heterocyclic cpds. EP 1029861; JP 1994184143; US 5206366 .
|
【3】
Howard, H.R. Jr.; Busch, F.R.; Grobin, A.W.; Leeman, K.R. (Pfizer Products Inc.); Controlled synthesis of ziprasidone and compsns. thereof. WO 0370246 .
|
【4】
Seeger, T.F.; Prakash, C.; Howard, H.R.; Ziprasidone Hydrochloride. Drugs Fut 1994, 19, 6, 560.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(I) |
16274 |
6-chloro-1H-indole-2,3-dione; 6-Chloroisatin
|
6341-92-0 |
C8H4ClNO2 |
详情 | 详情
|
(II) |
16275 |
6-chloro-1,3-dihydro-2H-indol-2-one
|
56341-37-8 |
C8H6ClNO |
详情 | 详情
|
(III) |
16276 |
6-chloro-5-(2-chloroacetyl)-1,3-dihydro-2H-indol-2-one
|
|
C10H7Cl2NO2 |
详情 |
详情
|
(IV) |
16277 |
6-chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one; 5-chloroethyl-6-chloro-1,3-dihydro-1H-indol-2-one-
|
|
C10H9Cl2NO |
详情 |
详情
|
(V) |
16278 |
1,2-benzisothiazol-3(2H)-one; 1,2-Benzisothiazolin-3-one
|
2634-33-5 |
C7H5NOS |
详情 | 详情
|
(VI) |
16279 |
3-chloro-1,2-benzisothiazole
|
|
C7H4ClNS |
详情 |
详情
|
(VII) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
合成路线42
该中间体在本合成路线中的序号:
(II) A new, one-step commercial process for the preparation of 3-(1-piperazinyl)-1,2-benzisothiazole, a key intermediate in the synthesis of ziprasidone has been developed: The reaction of 2-cyanophenyl disulfide (I) with piperazine (II) by means of DMSO and isopropanol at 120-5 C.
【1】
Sinay, T.G.; Fox, D.E.; Walinsky, S.W.; Lambert, J.F.; New disulfide route to 3-(1-piperazinyl)-1,2-benzisothiazole. Nucleus for atypical antipsychotic drugs. Org Process Res Dev 1999, 3, 2, 126.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
37621 |
2-[(2-cyanophenyl)disulfanyl]benzonitrile
|
33174-74-2 |
C14H8N2S2 |
详情 | 详情
|
(II) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
合成路线43
该中间体在本合成路线中的序号:
(IV) The bromination of 3-chloro-1,2-benzoisothiazole (I) with Br2 in AcOH using FeCl3 as catalyst gives a mixture of 3,5-dibromo-1,2-benzoisothiazole (II) and 3,7-dibromo-1,2-benzoisothiazole (III) that are separated by flash chromatography. The desired isomer (III) is condensed with piperazine (IV) in refluxing diglyme to yield 7-bromo-3-(1-piperazinyl)-1,2-benzoisothiazole (V), which is condensed with 6-chloro-5-(2-chloroethyl)indolin-2-one (VI) by means of Na2CO3 in refluxing water to afford the brominated adduct (VII). Finally, this compound is debrominated with tritium gas over a Pd/BaSO4 catalyst in THF to provide the target radiolabeled compound.
【1】
Howard, H.R.; Shenk, K.D.; Smolarek, T.A.; Marx, M.H.; Windels, J.H.; Roth, R.W.; Synthesis of H-3- and C-14-labelled CP-88,059: A potent atypical antipsychotic agent. J Label Compd Radiopharm 1994, 34, 2, 117.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16279 |
3-chloro-1,2-benzisothiazole
|
|
C7H4ClNS |
详情 |
详情
|
(II) |
62886 |
3,5-dibromo-1,2-benzisothiazole
|
|
C7H3Br2NS |
详情 |
详情
|
(III) |
62887 |
3,7-dibromo-1,2-benzisothiazole
|
|
C7H3Br2NS |
详情 |
详情
|
(IV) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(V) |
62888 |
7-bromo-3-(1-piperazinyl)-1,2-benzisothiazole
|
|
C11H12BrN3S |
详情 |
详情
|
(VI) |
16277 |
6-chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one; 5-chloroethyl-6-chloro-1,3-dihydro-1H-indol-2-one-
|
|
C10H9Cl2NO |
详情 |
详情
|
(VII) |
62889 |
5-{2-[4-(7-bromo-1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
|
|
C21H20BrClN4OS |
详情 |
详情
|
合成路线44
该中间体在本合成路线中的序号:
(VIII) A synthesis for the 18F-labeled compound has also been reported. The piperazinylquinoxaline (IX) was obtained from chloroquinoxaline (VI) and excess piperazine (VIII) at 160 C. This was then alkylated with 4-[18F]fluorobenzyl iodide (X) in refluxing CH2Cl2 to provide the labeled product.
【1】
Katounina, T.; et al.; Synthesis and biological investigations of [18F]MR. Bioorg Med Chem 1998, 6, 6, 789.
|
【2】
Lancelot, J.-C.; Prunier, H.; Rault, S.; et al.; Novel and selective partial agonists of 5-HT3 rece. J Med Chem 1997, 40, 12, 1808.
|
【3】
Katounina, T.; et al.; Synthesis of [18F]MR 18445 and its in vivo evaluat. J Label Compd Radiopharm 1997, 40, 542.
|
【4】
Rault, S.; Lancelot, J.-C.; Prunier, H.; Robba, M.; Delagrange, P.; Renard, P.; Adam, G. (ADIR et Cie.); Pyrrolopyrazine derivs. with 5-HT3 activity. CA 2122890; EP 0623620; FR 2704547; JP 1994340666; US 5599812 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
23597 |
4-chloropyrrolo[1,2-a]quinoxalin-7-yl methyl ether; 4-chloro-7-methoxypyrrolo[1,2-a]quinoxaline
|
|
C12H9ClN2O |
详情 |
详情
|
(VIII) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(IX) |
23600 |
7-methoxy-4-(1-piperazinyl)pyrrolo[1,2-a]quinoxaline; methyl 4-(1-piperazinyl)pyrrolo[1,2-a]quinoxalin-7-yl ether
|
|
C16H18N4O |
详情 |
详情
|
(X) |
23601 |
1-fluoro-4-(iodomethyl)benzene
|
|
C7H6FI |
详情 |
详情
|
(X) |
45316 |
1-fluoro-4-(iodomethyl)benzene
|
|
C7H6FI |
详情 |
详情
|
合成路线45
该中间体在本合成路线中的序号:
(XVI) Condensation of the anti-bromo derivative (XII) with piperazine (XVI) in refluxing acetonitrile provides 1-[10,11-(difluoromethano)dibenzosuber-5-yl]piperazine as a mixture of syn- and anti-isomers (XVII), which is separated by crystallization. Finally, the desired anti-isomer (VIII) is condensed with 5-[2(R),3-epoxypropoxy]quinoline (IX) in hot ethanol.
【1】
Sorbera, L.A.; Castaner, J.; Silvestre, J.S.; Bayes, M.; Zosuquidar Trihydrochloride.. Drugs Fut 2003, 28, 2, 125-136.
|
【2】
Barnett, C.J.; Wilson, T.M.; Astleford, B.A.; Kobierski, M.E. (Eli Lilly and Company); Process for preparing a 10,11-methanodibenzosuberane deriv.. WO 0075132 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VIII) |
56207 |
1-[(1aR,10bS)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazine
|
|
C20H20F2N2 |
详情 |
详情
|
(IX) |
56211 |
(2R)oxiranylmethyl 5-quinolinyl ether; 5-[(2R)oxiranylmethoxy]quinoline
|
|
C12H11NO2 |
详情 |
详情
|
(XII) |
56208 |
(1aR,10bS)-6-bromo-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cycloheptene
|
|
C16H11BrF2 |
详情 |
详情
|
(XVI) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(XVII) |
59523 |
1-[(1aR,10bS)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazine
|
|
C20H20F2N2 |
详情 |
详情
|
合成路线46
该中间体在本合成路线中的序号:
(IV) Ketone (I) was reduced with sodium borohydride in methanol to alcohol (II), which was then converted into chloride (III) on treatment with thionyl chloride in cooled toluene. Alkylation of piperazine (IV) with chloride (III) in the presence of triethylamine gave V. Finally, piperazine (V) was condensed with 4-pyridylacetic acid (VI) in the presence of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (DEC), 1-hydroxybenzotriazole (HOBt), and N-methylmorpholine in DMF to afford the target amide.
【1】
Lesur, B.; et al.; New deoxynojirimycin derivatives as potent inhibitors of intestinal alpha-glucohydrolases. Bioorg Med Chem Lett 1997, 7, 3, 355-360.
|
【2】
Lesur, B.; Ducep, J.-B.; Danzin, C. (Merrell Pharmaceuticals, Inc.); Novel nojirimycin derivs.. EP 0453692; EP 0454580; JP 1993086072; US 5252587; US 5536732 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16504 |
8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one; 8-Chloro-10,11-dihydro-4-aza-5H-dibenzo[a,d]cycloheptan-5-one
|
31251-41-9 |
C14H10ClNO |
详情 | 详情
|
(II) |
17935 |
8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ol
|
|
C14H12ClNO |
详情 |
详情
|
(III) |
17936 |
8,11-dichloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
|
|
C14H11Cl2N |
详情 |
详情
|
(IV) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(V) |
17938 |
8-chloro-11-(1-piperazinyl)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
|
|
C18H20ClN3 |
详情 |
详情
|
(VI) |
17883 |
2-(4-pyridinyl)acetic acid
|
28356-58-3 |
C7H7NO2 |
详情 | 详情
|
合成路线47
该中间体在本合成路线中的序号:
(IV) The condensation of 4-chlorophenylsulfonate (I) with 4-bromophenol (II) by means of K2CO3 in hot DMF gives the aryl ether (III), which is condensed with piperazine (IV) by means of Pdo to yield the monosubstituted piperazine (V). Finally, this compound is condensed with the 4-bromophenyltriazolone (VI) by means of K2CO3 in hot DMSO to afford the target disubstituted piperazine
【1】
Hepperle, M.; Eckert, J.; Gala, D.; Shen, L.; Evans, C.A.; Goodman, A.; Mono N-arylation of piperazine(III): Metal-catalyzed N-arylation and its application to the novel preparations of the antifungal posaconazole and its advanced intermediate. Tetrahedron Lett 2002, 43, 18, 3359. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17109 |
[(3S,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methyl 4-chlorobenzenesulfonate
|
|
C20H18ClF2N3O4S |
详情 |
详情
|
(II) |
25313 |
4-bromophenol
|
106-41-2 |
C6H5BrO |
详情 | 详情
|
(III) |
64328 |
1-{[(2R,4R)-4-[(4-bromophenoxy)methyl]-2-(2,4-difluorophenyl)tetrahydro-2-furanyl]methyl}-1H-1,2,4-triazole; 4-bromophenyl [(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methyl ether
|
|
C20H18BrF2N3O2 |
详情 |
详情
|
(IV) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(V) |
64329 |
1-(4-{[(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methoxy}phenyl)piperazine; [(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methyl 4-(1-piperazinyl)phenyl ether
|
|
C24H27F2N5O2 |
详情 |
详情
|
(VI) |
64326 |
2-[(1S,2S)-2-(benzyloxy)-1-ethylpropyl]-4-(4-bromophenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
|
|
C20H22BrN3O2 |
详情 |
详情
|
合成路线48
该中间体在本合成路线中的序号:
(IV) Alternatively, the condensation of with the 4-bromophenyltriazolone (VI) with piperazine (IV) by means of Pd2(dba)3, BINAP and t-BuONa in hot toluene gives the monosubstituted piperazine (VII), which is then condensed with the already reported aryl ether (III) by means of Pd2(dba)3, BINAP and t-BuONa in hot toluene, and debenzylated with Pd/C and formic acid to afford the target disubstituted piperazine.
【1】
Hepperle, M.; Eckert, J.; Gala, D.; Shen, L.; Evans, C.A.; Goodman, A.; Mono N-arylation of piperazine(III): Metal-catalyzed N-arylation and its application to the novel preparations of the antifungal posaconazole and its advanced intermediate. Tetrahedron Lett 2002, 43, 18, 3359. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III) |
64328 |
1-{[(2R,4R)-4-[(4-bromophenoxy)methyl]-2-(2,4-difluorophenyl)tetrahydro-2-furanyl]methyl}-1H-1,2,4-triazole; 4-bromophenyl [(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methyl ether
|
|
C20H18BrF2N3O2 |
详情 |
详情
|
(IV) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(VI) |
64326 |
2-[(1S,2S)-2-(benzyloxy)-1-ethylpropyl]-4-(4-bromophenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
|
|
C20H22BrN3O2 |
详情 |
详情
|
(VII) |
64327 |
2-[(1S,2S)-2-(benzyloxy)-1-ethylpropyl]-4-[4-(1-piperazinyl)phenyl]-2,4-dihydro-3H-1,2,4-triazol-3-one
|
|
C24H31N5O2 |
详情 |
详情
|
合成路线49
该中间体在本合成路线中的序号:
(II) The intermediate 4-[4-(4-aminophenyl)piperazin-1-yl]phenol (VIII) has been obtained by several related ways:
1.- The condensation of 4-bromonitrobenzene (I) with piperazine (II) gives 1-(4-nitrophenyl)piperazine (III), which is condensed with 4-bromoanisole (IV) by means of Pdo to yield 1-(4-methoxyphenyl)-4-(4-nitrophenyl)piperazine (V). Alternatively, (V) can also be obtained by condensation of (III) with 4-methoxyphenylboronic acid (VI) by means of Cu(OAc)2 in DMSO. The demethylation of (V) with HBr yields 4-[4-(4-nitrophenyl)piperazin-1-yl]phenol (VII), which is finally reduced with H2 over Pd/C to afford the target 4-[4-(4-aminophenyl)piperazin-1-yl]phenol (VIII) intermediate (see Synthline, scheme no. 22656202a, intermediate (XIV)).
2.- The condensation of piperazine (II) with 4-bromoanisole (IV) by means of Pdo gives 1-(4-methoxyphenyl)piperazine (IX), which is condensed with 4-bromonitrobenzene (I) by means of K2CO3 and tetrabutylammonium iodide (TBAI) in hot DMSO to yield intermediate 1-(4-methoxyphenyl)-4-(4-nitrophenyl)piperazine (V), already reported.
3.- The condensation of piperazine (II) with 4-(benzyloxy)phenyl bromide (X) by means of Pdo gives 1-(4-benzyloxyphenyl)piperazine (XI), which is condensed with 4-bromonitrobenzene (I) by means of K2CO3 and TBAI in hot DMSO to yield 1-(4-benzyloxyphenyl)-4-(4-nitrophenyl)piperazine (XII). The nitro group of (XII) is reduced by means of H2 (50 psi) over Pd/C in wet THF at 50? C to afford 4-[4-(4-benzyloxyphenyl)piperazin-1-yl]aniline (XIII), which is finally debenzylated with H2 (80 psi) over Pd/C in wet THF at 70? C or other drastic conditions to afford the target 4-[4-(4-aminophenyl)piperazin-1-yl]phenol (VIII) intermediate (see Synthline, scheme no. 22656202a, intermediate (XIV)).
Alternatively, 1-(4-benzyloxyphenyl)-4-(4-nitrophenyl)piperazine (XII) can also be reduced directly to the target intermediate (VIII) with H2 over Pd/C under a variety of drastic conditions.
【1】
Hepperle, M.; Eckert, J.; Gala, D.; Shen, L.; Evans, C.A.; Goodman, A.; Mono N-arylation of piperazine(III): Metal-catalyzed N-arylation and its application to the novel preparations of the antifungal posaconazole and its advanced intermediate. Tetrahedron Lett 2002, 43, 18, 3359. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26628 |
1-bromo-4-nitrobenzene
|
99-99-0 |
C6H4BrNO2 |
详情 | 详情
|
(II) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(III) |
20299 |
1-(4-nitrophenyl)piperazine
|
6269-89-2 |
C10H13N3O2 |
详情 | 详情
|
(IV) |
63436 |
1-bromo-4-methoxybenzene; 4-bromophenyl methyl ether
|
|
C7H7BrO |
详情 |
详情
|
(V) |
16314 |
methyl 4-[4-(4-nitrophenyl)piperazino]phenyl ether; 1-(4-methoxyphenyl)-4-(4-nitrophenyl)piperazine
|
|
C17H19N3O3 |
详情 |
详情
|
(VI) |
39246 |
4-methoxyphenylboronic acid
|
5720-07-0 |
C7H9BO3 |
详情 | 详情
|
(VII) |
16345 |
4-[4-(4-nitrophenyl)piperazino]phenol
|
|
C16H17N3O3 |
详情 |
详情
|
(VIII) |
17110 |
4-[4-(4-aminophenyl)piperazino]phenol; 1-(4-Aminophenyl)-4-(4-hydroxyphenyl)piperazine; 1-(4-Hydroxyphenyl)-4-(4-aminophenyl)piperazine
|
74853-08-0 |
C16H19N3O |
详情 | 详情
|
(IX) |
16312 |
1-(4-Methoxyphenyl)piperazine; Methyl 4-piperazinophenyl ether
|
38212-30-5 |
C11H16N2O |
详情 | 详情
|
(X) |
43156 |
1-(benzyloxy)-4-bromobenzene; benzyl 4-bromophenyl ether
|
6793-92-6 |
C13H11BrO |
详情 | 详情
|
(XI) |
64373 |
1-[4-(benzyloxy)phenyl]piperazine; benzyl 4-(1-piperazinyl)phenyl ether
|
|
C17H20N2O |
详情 |
详情
|
(XII) |
64372 |
benzyl 4-[4-(4-nitrophenyl)-1-piperazinyl]phenyl ether; 1-[4-(benzyloxy)phenyl]-4-(4-nitrophenyl)piperazine
|
|
C23H23N3O3 |
详情 |
详情
|
(XIII) |
64371 |
4-{4-[4-(benzyloxy)phenyl]-1-piperazinyl}aniline; 4-{4-[4-(benzyloxy)phenyl]-1-piperazinyl}phenylamine
|
|
C23H25N3O |
详情 |
详情
|
合成路线50
该中间体在本合成路线中的序号:
(V) This compound can be obtained by two different ways:
1) The acetylation of 1-nitrosopiperazine (I) with acetyl chloride and pyridine in dioxane gives 1-acetyl-4-nitrosopiperazine (II), which is reduced with Zn and acetic acid/water to 1-acetyl-4-aminopiperazine (III). Finally, this compound is acylated with 4-fluorobenzoyl chloride (IV) by means of triethylamine in dichloromethane.
2) The nitrosation of piperazine (V) with NaNO2/HCl in water, followed by condensation with benzyloxycarbonyl chloride (VI) by means of NaOH yields 1-(benzyloxycarbonyl)-4-nitrosopiperazine (VII), which is reduced with Zn and acetic acid/water as before to the corresponding amino derivative (VIII). The acylation of (VIII) with 4-fluorobenzoyl chloride and triethylamine in dichloromethane affords N-[4-(benzyloxycarbonyl)piperazin-1-yl]-4-fluorobenzamide (IX), which is deprotected with HBr in acetic acid to yield N-(1-piperazinyl)-4-fluorobenzamide (X). Finally, this compound is acetylated with acetic anhydride/NaOH in water.
【1】
Graul, A.; Tracy, M.; Castañer, J.; FK-960. Drugs Fut 1997, 22, 8, 830.
|
【2】
Oku, T.; Todo, E.; Yokota, Y.; Kayakiri, H.; Hashimoto, M. (Fujisawa Pharmaceutical Co., Ltd.); New aminopiperazine derivs. EP 0436734; JP 1991510050; US 5250528; WO 9101979 .
|
【3】
Oku, T.; Kayakiri, H.; Tanaka, H. (Fujisawa Pharmaceutical Co., Ltd.); Novel intermediate for synthetic use and process for producing aminopiperazine derivs. WO 9500502 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17260 |
1-nitrosopiperazine
|
|
C4H9N3O |
详情 |
详情
|
(II) |
17261 |
1-(4-nitrosopiperazino)-1-ethanone
|
|
C6H11N3O2 |
详情 |
详情
|
(III) |
17262 |
1-(4-aminopiperazino)-1-ethanone
|
|
C6H13N3O |
详情 |
详情
|
(IV) |
17263 |
4-fluorobenzoyl chloride
|
403-43-0 |
C7H4ClFO |
详情 | 详情
|
(V) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(VI) |
10101 |
Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene
|
501-53-1 |
C8H7ClO2 |
详情 | 详情
|
(VII) |
17266 |
benzyl 4-nitrosotetrahydro-1(2H)-pyrazinecarboxylate
|
|
C12H15N3O3 |
详情 |
详情
|
(VIII) |
17267 |
benzyl 4-aminotetrahydro-1(2H)-pyrazinecarboxylate
|
|
C12H17N3O2 |
详情 |
详情
|
(IX) |
17268 |
benzyl 4-[(4-fluorobenzoyl)amino]tetrahydro-1(2H)-pyrazinecarboxylate
|
|
C19H20FN3O3 |
详情 |
详情
|
(X) |
17269 |
4-fluoro-N-piperazinobenzamide
|
|
C11H14FN3O |
详情 |
详情
|
合成路线51
该中间体在本合成路线中的序号:
(II) Condensation of 3,4-difluoronitrobenzene (I) with an excess of piperazine (II) in refluxing acetonitrile yielded the 4-nitrophenylpiperazine (III), which was reduced to aniline (IV) by hydrogenation in the presence of Pd/C. Reaction with benzyl chloroformate provided the bis(carbamate) (V). This was treated with butyllithium at -78 C, and the resulting lithium salt was reacted with (R)-glycidyl butyrate (VI) to give chiral (R)-oxazolidinone (VII). Subsequent reaction with methanesulfonyl chloride, followed by displacement of the resulting mesylate with potassium phthalimide afforded the substituted phthalimide (VIII), which was deblocked with aqueous methylamine to give primary amine (IX). Further acetylation with Ac2O in pyridine yielded amide (IX) from which the N-carbobenzoxy group was removed by hydrogenolysis in the presence of Pd/C, providing the piperazine salt (XI). Alkylation of piperazine (XI) with 3,6-dichloropyridazine (XII) in DMF then gave the chloropyridazine derivative (XIII) and final hydrogenolysis of the halogen atom in the presence of palladium black yielded the title compound.
【1】
Brickner, S.J.; Hutchinson, D.K.; Barbachyn, M.R.; et al.; Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant Gram-positive bacterial infections. J Med Chem 1996, 39, 3, 673. |
【2】
Tucker, J.A.; Allwine, D.A.; Grega, K.C.; Barbachyn, M.R.; Klock, J.L.; Adamski, J.L.; Brickner, S.J.; Hutchinson, D.K.; Ford, C.W.; Zurenko, G.E.; Conradi, R.A.; Burton, P.S.; Jensen, R.M.; Piperazinyl oxazolidinone antibacterial agents containing a pyridine, diazene, or triazene heteroaromatic ring. J Med Chem 1998, 41, 19, 3727. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17013 |
1,2-difluoro-4-nitrobenzene; 3,4-Difluoronitrobenzene
|
369-34-6 |
C6H3F2NO2 |
详情 | 详情
|
(II) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(III) |
18382 |
1-(2-fluoro-4-nitrophenyl)piperazine
|
|
C10H12FN3O2 |
详情 |
详情
|
(IV) |
18383 |
3-fluoro-4-(1-piperazinyl)phenylamine; 3-fluoro-4-(1-piperazinyl)aniline
|
|
C10H14FN3 |
详情 |
详情
|
(V) |
18384 |
benzyl 4-(4-[[(benzyloxy)carbonyl]amino]-2-fluorophenyl)-1-piperazinecarboxylate
|
|
C26H26FN3O4 |
详情 |
详情
|
(VI) |
18385 |
(2R)oxiranylmethyl butyrate;(R)-glycidyl butyrate |
60456-26-0 |
C7H12O3 |
详情 | 详情
|
(VII) |
18386 |
benzyl 4-[2-fluoro-4-[(5R)-5-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]-1-piperazinecarboxylate
|
|
C22H24FN3O5 |
详情 |
详情
|
(VIII) |
18387 |
benzyl 4-(4-[(5S)-5-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-2-oxo-1,3-oxazolidin-3-yl]-2-fluorophenyl)-1-piperazinecarboxylate
|
|
C30H27FN4O6 |
详情 |
详情
|
(IX) |
18388 |
benzyl 4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]-2-fluorophenyl]-1-piperazinecarboxylate
|
|
C22H25FN4O4 |
详情 |
详情
|
(X) |
18389 |
benzyl 4-(4-[(5S)-5-[(acetamido)methyl]-2-oxo-1,3-oxazolidin-3-yl]-2-fluorophenyl)-1-piperazinecarboxylate
|
|
C24H27FN4O5 |
详情 |
详情
|
(XI) |
18390 |
N-([(5S)-3-[3-fluoro-4-(1-piperazinyl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl)acetamide
|
|
C16H21FN4O3 |
详情 |
详情
|
(XIII) |
18393 |
N-[((5S)-3-[4-[4-(6-chloro-3-pyridazinyl)-1-piperazinyl]-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl)methyl]acetamide
|
|
C20H22ClFN6O3 |
详情 |
详情
|
合成路线52
该中间体在本合成路线中的序号:
(II) Condensation of 3,4-difluoronitrobenzene (I) with an excess of piperazine (II) in refluxing acetonitrile yielded the 4-nitrophenylpiperazine (III), which was reduced to aniline (IV) by hydrogenation in the presence of Pd/C. Reaction with benzyl chloroformate provided the bis(carbamate) (V). This was treated with butyllithium at -78 C, and the resulting lithium salt was reacted with (R)-glycidyl butyrate (VI) to give chiral (R)-oxazolidinone (VII). Subsequent reaction with methanesulfonyl chloride, followed by displacement of the resulting mesylate with potassium phthalimide afforded the substituted phthalimide (VIII), which was deblocked with aqueous methylamine to give primary amine (IX). Further acetylation with Ac2O in pyridine yielded amide (IX) from which the N-carbobenzoxy group was removed by hydrogenolysis in the presence of Pd/C, providing the piperazine salt (XI). Then, alkylation of piperazine (XI) with 3-chloro-6-methylpyridazine (XII) in dimethylpropyleneurea (DMPU) at 90 C yielded the title compound.
【1】
Brickner, S.J.; Hutchinson, D.K.; Barbachyn, M.R.; et al.; Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant Gram-positive bacterial infections. J Med Chem 1996, 39, 3, 673. |
【2】
Tucker, J.A.; Allwine, D.A.; Grega, K.C.; Barbachyn, M.R.; Klock, J.L.; Adamski, J.L.; Brickner, S.J.; Hutchinson, D.K.; Ford, C.W.; Zurenko, G.E.; Conradi, R.A.; Burton, P.S.; Jensen, R.M.; Piperazinyl oxazolidinone antibacterial agents containing a pyridine, diazene, or triazene heteroaromatic ring. J Med Chem 1998, 41, 19, 3727. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17013 |
1,2-difluoro-4-nitrobenzene; 3,4-Difluoronitrobenzene
|
369-34-6 |
C6H3F2NO2 |
详情 | 详情
|
(II) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(III) |
18382 |
1-(2-fluoro-4-nitrophenyl)piperazine
|
|
C10H12FN3O2 |
详情 |
详情
|
(IV) |
18383 |
3-fluoro-4-(1-piperazinyl)phenylamine; 3-fluoro-4-(1-piperazinyl)aniline
|
|
C10H14FN3 |
详情 |
详情
|
(V) |
18384 |
benzyl 4-(4-[[(benzyloxy)carbonyl]amino]-2-fluorophenyl)-1-piperazinecarboxylate
|
|
C26H26FN3O4 |
详情 |
详情
|
(VI) |
18385 |
(2R)oxiranylmethyl butyrate;(R)-glycidyl butyrate |
60456-26-0 |
C7H12O3 |
详情 | 详情
|
(VII) |
18386 |
benzyl 4-[2-fluoro-4-[(5R)-5-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]-1-piperazinecarboxylate
|
|
C22H24FN3O5 |
详情 |
详情
|
(VIII) |
18387 |
benzyl 4-(4-[(5S)-5-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-2-oxo-1,3-oxazolidin-3-yl]-2-fluorophenyl)-1-piperazinecarboxylate
|
|
C30H27FN4O6 |
详情 |
详情
|
(IX) |
18388 |
benzyl 4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]-2-fluorophenyl]-1-piperazinecarboxylate
|
|
C22H25FN4O4 |
详情 |
详情
|
(X) |
18389 |
benzyl 4-(4-[(5S)-5-[(acetamido)methyl]-2-oxo-1,3-oxazolidin-3-yl]-2-fluorophenyl)-1-piperazinecarboxylate
|
|
C24H27FN4O5 |
详情 |
详情
|
(XI) |
18390 |
N-([(5S)-3-[3-fluoro-4-(1-piperazinyl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl)acetamide
|
|
C16H21FN4O3 |
详情 |
详情
|
(XII) |
13485 |
2,8-Dimethyl-3-methylene-1-oxa-8-azaspiro[4.5]decane
|
|
C11H19NO |
详情 |
详情
|
合成路线53
该中间体在本合成路线中的序号:
(XI) The Knoevenagel condensation between methyl acetoacetate (I) and 3,4-difluorobenzaldehyde (II) afforded the benzylidene derivative (III), which was cyclized with O-methylisourea hemisulfate (IV), yielding the dihydropyrimidine (V). This compound, upon reaction with 4-nitrophenyl chloroformate, regioselectively produced the carbamate ester (VI) (1,2). Treatment of (VI) with aqueous HCl gave the dihydropyrimidinone (VII), which was subsequently coupled with 3-bromopropylamine·HBr (VIII) to give the bromopropyl amide (IX) (1). The intermediate N-(2-carboxamidophenyl)piperazine (XIII) was obtained by condensation of 2-bromobenzonitrile (X) with piperazine (XI), followed by partial hydrolysis of the nitrile group with H2SO4. The title compound was finally obtained by condensation between piperazine (XIII) and bromide (IX) in the presence of KI and K2CO3 in refluxing acetone.
【1】
Lagu, B.; Nagarathnam, D.; Miao, S.W.; et al.; Design and synthesis of novel alpha1a adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones. J Med Chem 1999, 42, 23, 4764.
|
【2】
Marzabadi, M.R.; Murali Dhar, T.G.; Nagarathnam, D.; et al.; Design and synthesis of novel alpha1a adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety. J Med Chem 1999, 42, 23, 4778. |
【3】
Wong, W.C.; Lagu, B.; Nagarathnam, D.; Marzabadi, M.R.; Gluchowski, C. (Synaptic Pharmaceutical Corp.); Dihydropyrimidines and uses thereof. EP 1021185; JP 2000506904; WO 9742956 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11791 |
methyl 3-oxobutanoate; Methyl acetoacetate
|
105-45-3 |
C5H8O3 |
详情 | 详情
|
(II) |
26654 |
3,4-difluorobenzaldehyde
|
34036-07-2 |
C7H4F2O |
详情 | 详情
|
(III) |
38075 |
methyl (Z)-2-acetyl-3-(3,4-difluorophenyl)-2-propenoate
|
|
C12H10F2O3 |
详情 |
详情
|
(IV) |
26657 |
O-methyl isourea; [Amino(imino)methoxy]methane
|
52328-05-9 |
C2H6N2O |
详情 | 详情
|
(V) |
38076 |
methyl 6-(3,4-difluorophenyl)-2-methoxy-4-methyl-1,6-dihydro-5-pyrimidinecarboxylate
|
|
C14H14F2N2O3 |
详情 |
详情
|
(VI) |
43072 |
5-benzyl 1-(4-nitrophenyl) 6-(3,4-difluorophenyl)-2-methoxy-4-methyl-1,5(6H)-pyrimidinedicarboxylate
|
|
C27H21F2N3O7 |
详情 |
详情
|
(VII) |
43073 |
5-benzyl 1-(4-nitrophenyl) 6-(3,4-difluorophenyl)-4-methyl-2-oxo-3,6-dihydro-1,5(2H)-pyrimidinedicarboxylate
|
|
C26H19F2N3O7 |
详情 |
详情
|
(VIII) |
25449 |
3-bromo-1-propanamine; 3-bromopropylamine
|
18370-81-5 |
C3H8BrN |
详情 | 详情
|
(IX) |
43074 |
benzyl 3-[[(3-bromopropyl)amino]carbonyl]-4-(3,4-difluorophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate
|
|
C23H22BrF2N3O4 |
详情 |
详情
|
(X) |
15541 |
o-bromobenzonitrile; 2-bromobenzonitrile
|
2042-37-7 |
C7H4BrN |
详情 | 详情
|
(XI) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(XII) |
43075 |
2-(1-piperazinyl)benzonitrile
|
|
C11H13N3 |
详情 |
详情
|
(XIII) |
43076 |
2-(1-piperazinyl)benzamide
|
|
C11H15N3O |
详情 |
详情
|
合成路线54
该中间体在本合成路线中的序号:
(V) Condensation of trimethylhydroquinone (I) with 4-chloro-1-butanol (II) in the presence of phosphomolybdic acid in refluxing toluene yielded the chlorobutyl ether (III). Benzhydrylpiperazine (VI), (prepared from chlorodiphenylmethane (IV) and piperazine (V)), was then condensed with chloride (III) to give the target compound, which was isolated as the dihydrochloride salt.
【1】
Kawasaki, N.; Satoh, T.; Nagai, H.; Nishiki, M.; Matsumoto, H.; Inagaki, N.; Miyataka, H.; Synthesis of trimethylhydroquinone derivatives as anti-allergic agents with anti-oxidative actions. Chem Pharm Bull 1999, 47, 2, 177.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26357 |
2,3,5-trimethyl-1,4-benzenediol
|
700-13-0 |
C9H12O2 |
详情 | 详情
|
(II) |
22336 |
4-chloro-1-butanol
|
928-51-8 |
C4H9ClO |
详情 | 详情
|
(III) |
27973 |
4-(4-chlorobutoxy)-2,3,6-trimethylphenol
|
|
C13H19ClO2 |
详情 |
详情
|
(IV) |
27974 |
Benzhydrylchloride; 1,1-Diphenylchloromethane; Dibenzyl chloride; Alpha-Chlorodiphenylmethane; Chlorodiphenylmethane; Diphenylchloromethane; 1-[chloro(phenyl)methyl]benzene
|
90-99-3 |
C13H11Cl |
详情 | 详情
|
(V) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(VI) |
20796 |
N-(Benzhydryl)piperazine; 1-Benzhydrylpiperazine; 1-(dibenzyl)piperazine
|
841-77-0 |
C17H20N2 |
详情 | 详情
|
合成路线55
该中间体在本合成路线中的序号:
(VII) This compound has been obtained by two different ways:
1) The condensation of 2-bromobenzyl alcohol (I) with cyclohexane-1,4-dione monoethyleneketal (II) by means of BuLi in THF gives the expected adduct (III), which is cyclized and deprotected with TFA yielding the spirocyclohexanone (IV). The reduction of (IV) with NaBH4 in ethanol affords the cis-spirocyclohexanol (V), which by reaction with MsCl and TEA in dichloromethane is converted into the mesylate (VI). The condensation of (VI) with piperazine (VII) in refluxing isopropanol provides the trans-intermediate (VIII), which is finally condensed with 2,4-difluorobenzonitrile (IX) by means of K2CO3 in refluxing acetonitrile.
2) The condensation of piperazine (VII) with 2,4-difluorobenzonitrile (IX) by means of K2CO3 in acetonitrile gives 2-fluoro-4-(1-piperazinyl)benzonitrile (X), which is then reductocondensed with spirocyclohexanone (IV) by means of NaBH4 and 2-ethylhexanoic acid in CH2Cl2 to afford the target compound.
【1】
Urban, F.J.; et al.; Synthesis of a spiro[cyclohex-1,1'-isobenzofuranyl]dopamine receptor antagonist. Org Process Res Dev 1999, 3, 6, 460.
|
【2】
Butler, T.W.; Fliri, A.F.J. (Pfizer Inc.); Spirocyclic dopamine receptor subtype ligands. EP 0925291; JP 2000502360; WO 9808835 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
36939 |
(2-bromophenyl)methanol
|
18982-54-2 |
C7H7BrO |
详情 | 详情
|
(II) |
16775 |
3,3-Dimethyl-1,5-dioxaspiro[5.5]undecan-9-one; 1,4-Cyclohexanedione mono-2,2-dimethyltrimethylene ketal
|
69225-59-8 |
C11H18O3 |
详情 | 详情
|
(III) |
36940 |
9-[2-(hydroxymethyl)phenyl]-3,3-dimethyl-1,5-dioxaspiro[5.5]undecan-9-ol
|
|
C18H26O4 |
详情 |
详情
|
(IV) |
36941 |
|
|
C13H14O2 |
详情 |
详情
|
(V) |
36942 |
|
|
C13H16O2 |
详情 |
详情
|
(VI) |
36943 |
|
|
C14H18O4S |
详情 |
详情
|
(VII) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(VIII) |
36944 |
|
|
C17H24N2O |
详情 |
详情
|
(IX) |
36945 |
2,4-difluorobenzonitrile
|
64248-64-2 |
C7H3F2N |
详情 | 详情
|
(X) |
36946 |
2-fluoro-4-(1-piperazinyl)benzonitrile
|
|
C11H12FN3 |
详情 |
详情
|
合成路线56
该中间体在本合成路线中的序号:
(VI) Chemoselective protection of the amino group of 2,3,5-trimethyl-4-aminophenol (I) with di-tert-butyl dicarbonate (Boc)2O in THF gives compound (II), which is then treated with NaH and (S)-glycidyl 3-nitrobenzenesulfonate (III) to yield epoxypropane (IV).
On the other hand, treatment of 4,4'-difluorobenzophenone (V) with piperazine (VI) in acetonitrile in the presence of Et3N gives derivative (VII), which is reduced with Et3siH in the presence of H2SO4 and TFA to afford piperazine (VIII). Condensation of epoxypropane (IV) with piperazine (VIII) in refluxing 2-propanol furnishes compound (IX), which is finally converted into the desired product by first removal of the Boc group by exposure to TFA in CH2Cl2, followed by treatment with methanesulfonic acid (MeSO3H).
【2】
Nakanishi, K.; Annoura, H.; Tamura, S. (Suntory Ltd.); Arylpiperidinopropanol and arylpiperazinopropanol derivs. and pharmaceuticals containing the same. CA 2276373; EP 0958280; WO 9923072 .
|
【1】
Tamura-Horikawa, Y.; Miyajima, A.; Tamura, S.; Annoura, H.; Imajo, S.; Toba, T.; Takemoto, N.; Nakanishi, K.; Discovery of (2S)-1-(4-amino-2,3,5-trimethylphenoxy)-3-(4-[4-(4-fluorobenzyl)phenyl)-1-piperazinyl)-2-propanol dimethanesulfonate (SUN N8075): A dual Na+ and Ca2+ channel blocker with antioxidant activity. J Med Chem 2000, 43, 18, 3372. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
45629 |
4-amino-2,3,5-trimethylphenol
|
|
C9H13NO |
详情 |
详情
|
(II) |
45630 |
tert-butyl 4-hydroxy-2,3,6-trimethylphenylcarbamate
|
|
C14H21NO3 |
详情 |
详情
|
(III) |
45631 |
(2S)oxiranylmethyl 4-nitrobenzenesulfonate
|
|
C9H9NO6S |
详情 |
详情
|
(IV) |
45632 |
tert-butyl 2,3,6-trimethyl-4-[(2S)oxiranylmethoxy]phenylcarbamate
|
|
C17H25NO4 |
详情 |
详情
|
(V) |
45633 |
bis(4-fluorophenyl)methanone; 4,4'-Difluorobenzophenone
|
345-92-6 |
C13H8F2O |
详情 | 详情
|
(VI) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(VII) |
45634 |
(4-fluorophenyl)[4-(1-piperazinyl)phenyl]methanone
|
|
C17H17FN2O |
详情 |
详情
|
(VIII) |
45635 |
1-[4-(4-fluorobenzyl)phenyl]piperazine
|
|
C17H19FN2 |
详情 |
详情
|
(IX) |
45636 |
tert-butyl 4-[((2S)-3-[4-[4-(4-fluorobenzyl)phenyl]-1-piperazinyl]-2-hydroxypropyl)oxy]-2,3,6-trimethylphenylcarbamate
|
|
C34H44FN3O4 |
详情 |
详情
|
合成路线57
该中间体在本合成路线中的序号:
(V) Condensation of ethyl cyclopentanone-2-carboxylate (I) with pyrazolyl amine (II) in boiling AcOH produced pyrazolopyrimidinol (III), which was then chlorinated by means of POCl3 to give (IV). Finally, displacement of the chlorine atom of (IV) with piperazine in hot DMF furnished the title compound.
【1】
Stadler, H.; Boes, M.; Riemer, C. (F. Hoffmann-La Roche AG); Pyrazolopyrimidines and pyrazolotriazines with 5-HT6 receptor affinity. EP 0941994; JP 2000186090 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29947 |
ethyl 2-oxocyclopentanecarboxylate
|
611-10-9 |
C8H12O3 |
详情 | 详情
|
(II) |
33690 |
3-(methylsulfanyl)-4-(phenylsulfonyl)-1H-pyrazol-5-ylamine; 3-(methylsulfanyl)-4-(phenylsulfonyl)-1H-pyrazol-5-amine
|
|
C10H11N3O2S2 |
详情 |
详情
|
(III) |
33691 |
2-(methylsulfanyl)-3-(phenylsulfonyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidin-8-ol
|
|
C16H15N3O3S2 |
详情 |
详情
|
(IV) |
33692 |
8-chloro-2-(methylsulfanyl)-3-(phenylsulfonyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine; 8-chloro-2-(methylsulfanyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidin-3-yl phenyl sulfone
|
|
C16H14ClN3O2S2 |
详情 |
详情
|
(V) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
合成路线58
该中间体在本合成路线中的序号:
(II) The acylation of piperazine (II) with 4-nitrobenzoyl chloride (I) afforded a mixture of monoacylated (III) and diacylated (IV) products, which were separated by chromatography. Subsequent alkylation of monosubstituted piperazine (III) with 4-nitrophenethyl bromide (V) in the presence of K2CO3 and NaI yielded the title compound.
【1】
Kanojia, R.M.; Kauffman, J.; Salata, J.J.; Synthesis and class III type antiarrhythmic activity of 4-aroyl (and aryl)-1-aralkylpiperazines. Bioorg Med Chem Lett 2000, 10, 24, 2819.
|
【2】
Kanojia, R.M.; et al.; Synthesis and selective class III type antiarrhythmic activity of 4-aroyl (and aryl)-1-aralkylpiperazines. 219th ACS Natl Meet (March 26 2000, San Francisco) 2000, Abst MEDI 204.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18941 |
p-nitrobenzoyl chloride; 4-nitrobenzoyl chloride
|
122-04-3 |
C7H4ClNO3 |
详情 | 详情
|
(II) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(III) |
20011 |
(4-nitrophenyl)(1-piperazinyl)methanone
|
|
C11H13N3O3 |
详情 |
详情
|
(IV) |
40947 |
[4-(4-nitrobenzoyl)-1-piperazinyl](4-nitrophenyl)methanone
|
|
C18H16N4O6 |
详情 |
详情
|
(V) |
19191 |
1-(2-bromoethyl)-4-nitrobenzene
|
5339-26-4 |
C8H8BrNO2 |
详情 | 详情
|
合成路线59
该中间体在本合成路线中的序号:
(V) 8-Bromoquinoline (I) is treated with sec-BuLi in THF to afford lithium derivative (II), which then reacts with carbaldehyde (III) in THF to provide alcohol (IV). Finally, (IV) is converted into the desired compound by chlorination with SOCl2 in CH2Cl2 followed by reaction with piperazine (V) in refluxing acetonitrile.
【1】
Delorme, D.; Wei, Z.-Y.; Plobeck, N.; et al.; New diarylmethylpiperazines as potent and selective nonpeptide delta opioid receptor agonists with increased in vitro metabolic stability. J Med Chem 2000, 43, 21, 3878.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
45930 |
8-bromoquinoline
|
16567-18-3 |
C9H6BrN |
详情 | 详情
|
(II) |
45931 |
8-quinolinyllithium
|
|
C9H6LiN |
详情 |
详情
|
(III) |
45932 |
N,N-diethyl-4-formylbenzamide
|
|
C12H15NO2 |
详情 |
详情
|
(IV) |
45933 |
N,N-diethyl-4-[hydroxy(8-quinolinyl)methyl]benzamide
|
|
C21H22N2O2 |
详情 |
详情
|
(V) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
合成路线60
该中间体在本合成路线中的序号:
(VI) Nitration of quinazolone (I) by reaction with HNO3/H2SO4 affords 7-chloro-6-nitro-4-quinazolone (II), which is then chlorinated with phosphorus oxychloride (POCl3) to provide quinazoline (III). Selective amination of the quinazoline ring of (III) by reaction with 4-chlorophenethylamine (IV) in isopropanol in the presence of Et3N yields compound (V), which is finally converted into the desired compound by condensation with piperazine (VI) in refluxing butanol in the presence of DIEA. Alternatively the target product can be obtained by the following procedure: Condensation of quinazolone derivative (II) with piperazine (VI) in refluxing butanol in the presence of DIEA affords compound (VII), which is treated with POCl3 and finally subjected to condensation with 4-chlorophenethylamine (IV) in isopropanol in the presence of Et3N.
【1】
Matsumoto, M.; Hayashi, H.; Tomizawa, H.; Obara, F.; Nagasaki, T.; Tobe, M.; Isoba, Y.; Structure-activity relationships of quinazoline derivatives: Dual-acting compounds with inhibitory activities toward both TNF-alpha production and T cell proliferation. Bioorg Med Chem Lett 2001, 11, 4, 545. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
50077 |
7-chloro-4(3H)-quinazolinone
|
|
C8H5ClN2O |
详情 |
详情
|
(II) |
50078 |
7-chloro-6-nitro-4(3H)-quinazolinone
|
|
C8H4ClN3O3 |
详情 |
详情
|
(III) |
50079 |
4,7-dichloro-6-nitroquinazoline
|
|
C8H3Cl2N3O2 |
详情 |
详情
|
(IV) |
38459 |
methyl (2R,3R)-3-amino-2-(3-cyanobenzyl)butanoate
|
|
C13H16N2O2 |
详情 |
详情
|
(V) |
50080 |
N-(7-chloro-6-nitro-4-quinazolinyl)-N-(4-chlorophenethyl)amine; 7-chloro-N-(4-chlorophenethyl)-6-nitro-4-quinazolinamine
|
|
C16H12Cl2N4O2 |
详情 |
详情
|
(VI) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(VII) |
50081 |
6-nitro-7-(1-piperazinyl)-4(3H)-quinazolinone
|
|
C12H13N5O3 |
详情 |
详情
|
合成路线61
该中间体在本合成路线中的序号:
(V) Intramolecular cyclization of p-hydroxy-4-chlorobutyrophenone (I) under alkaline conditions yields cyclopropyl(4-hydroxyphenyl) ketone (II). The phenolic hydroxyl group is then alkylated by 1-bromo-3-chloropropane (III) to furnish the chloropropyl ether (IV). Subsequent condensation of alkyl chloride (IV) with piperazine (V) gives rise to the N-substituted piperazine (VI). This is then coupled with N-Boc-L-alanine (VII) in the presence of EDC/DMAP to afford amide (VIII) (1, 2). After acidic cleavage of the N-Boc protecting group, the resultant monosubstituted piperazine (IX) is acylated by furanoyl chloride (X) to furnish the target furamide derivative
【1】
Black, L.A.; Faghih, R.; Liu, H.; et al.; Acyl-D-alanine amides: Selective histamine H3 receptor antagonists. 224th ACS Natl Meet (Aug 18 2002, Boston) 2002, Abst MEDI 323.
|
【2】
Black, L.A.; Faghih, R.; Bennani, Y.L.; Liu, H.; Zhang, H.Q.; Dwight, W.J.; Gentles, R.G.; Phelan, K.M.; Vasudevan, A. (Abbott Laboratories Inc.); Cyclic and bicyclic diamino histamine-3 receptor antagonists. WO 0166534 .
|
【3】
Black, L.A.; Faghih, R.; Bennani, Y.L.; Liu, H.; Zhang, H.Q.; Dwight, W.J.; Gentles, R.G.; Phelan, K.M.; Vasudevan, A. (Abbott Laboratories Inc.); Cyclic and bicyclic diamino histamine-3 receptor antagonists. US 2001049367; US 6559140 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
62995 |
|
|
C10H11ClO2 |
详情 |
详情
|
(II) |
27425 |
cyclopropyl(4-hydroxyphenyl)methanone
|
|
C10H10O2 |
详情 |
详情
|
(III) |
10358 |
1-Bromo-3-chloropropane
|
109-70-6 |
C3H6BrCl |
详情 | 详情
|
(IV) |
62988 |
5-bromo-N-(1H-imidazol-2-yl)-6-quinoxalinamine; N-(5-bromo-6-quinoxalinyl)-N-(1H-imidazol-2-yl)amine
|
|
C11H8BrN5 |
详情 |
详情
|
(V) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(VI) |
62996 |
|
|
C17H24N2O2 |
详情 |
详情
|
(VII) |
15859 |
Boc-D-Alanine; (2R)-2-[(tert-butoxycarbonyl)amino]propionic acid
|
7764-95-6 |
C8H15NO4 |
详情 | 详情
|
(VIII) |
63042 |
|
|
C28H23ClN2O2 |
详情 |
详情
|
(IX) |
63043 |
|
|
C17H15ClN2O2 |
详情 |
详情
|
(X) |
26093 |
2-Furoyl chloride
|
527-69-5 |
C5H3ClO2 |
详情 | 详情
|
合成路线62
该中间体在本合成路线中的序号:
(V) Cyclization of 4-chloro-4'-hydroxybutyrophenone (I) in the presence of 50% aqueous NaOH produces cyclopropyl (4-hydroxyphenyl) ketone (II). This is then alkylated with 1-bromo-3-chloropropane (III) to afford the chloropropyl ether (IV). Chloride displacement in (IV) with an excess of piperazine (V) in the presence of KI and K2CO3 furnishes the monosubstituted piperazine (VI). Subsequent coupling of piperazine (VI) with N-Boc-L-alanine (VII) leads to amide (VIII). Finally, Boc group cleavage in (VIII) employing trifluoroacetic acid yields the title compound (1-3).
【1】
Faghih, R.; Dwight, W.; Black, L.; Liu, H.; Gentles, R.; Phelan, K.; Esbenshade, T.A.; Ireland, L.; Miller, T.R.; Kang, C.-H.; Krueger, K.M.; Fox, G.B.; Hancock; Bennani, Y.L.; Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: Binding preference for D-amino acids motifs. Bioorg Med Chem Lett 2002, 12, 15, 2035. |
【2】
Black, L.A.; Faghih, R.; Bennani, Y.L.; Liu, H.; Zhang, H.Q.; Dwight, W.J.; Gentles, R.G.; Phelan, K.M.; Vasudevan, A. (Abbott Laboratories Inc.); Cyclic and bicyclic diamino histamine-3 receptor antagonists. WO 0166534 .
|
【3】
Black, L.A.; Faghih, R.; Bennani, Y.L.; Liu, H.; Zhang, H.Q.; Dwight, W.J.; Gentles, R.G.; Phelan, K.M.; Vasudevan, A. (Abbott Laboratories Inc.); Cyclic and bicyclic diamino histamine-3 receptor antagonists. US 2001049367; US 6559140 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
62995 |
|
|
C10H11ClO2 |
详情 |
详情
|
(II) |
27425 |
cyclopropyl(4-hydroxyphenyl)methanone
|
|
C10H10O2 |
详情 |
详情
|
(III) |
10358 |
1-Bromo-3-chloropropane
|
109-70-6 |
C3H6BrCl |
详情 | 详情
|
(IV) |
62998 |
[4-(3-chloropropoxy)phenyl](cyclopropyl)methanone
|
|
C13H15ClO2 |
详情 |
详情
|
(V) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(VI) |
62996 |
|
|
C17H24N2O2 |
详情 |
详情
|
(VII) |
15859 |
Boc-D-Alanine; (2R)-2-[(tert-butoxycarbonyl)amino]propionic acid
|
7764-95-6 |
C8H15NO4 |
详情 | 详情
|
(VIII) |
64059 |
tert-butyl (1R)-2-(4-{3-[4-(cyclopropylcarbonyl)phenoxy]propyl}-1-piperazinyl)-1-methyl-2-oxoethylcarbamate
|
|
C25H37N3O5 |
详情 |
详情
|
合成路线63
该中间体在本合成路线中的序号:
(II) The condensation of 3,6-dichloropyridazine (I) with piperazine (II) by means of TEA in refluxing toluene gives 3-chloro-6-(1-piperazinyl)pyridazine (III), which is methylated with HCHO/ HCOOH at 110 C, yielding 3-chloro-6-(4-methylpiperazin-1-yl)pyridazine (IV). Finally, this compound is quaternized with methyl iodide in ethyl ether to provide the target dimethylpiperidinium salt.
【1】
Toma, L.; et al.; 6-Chloropyridazin-3-yl derivatives active as nicotinic agents: Synthesis, binding, and modeling studies. J Med Chem 2002, 45, 18, 4011.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11292 |
3,6-Dichloropyridazine
|
141-30-0 |
C4H2Cl2N2 |
详情 | 详情
|
(II) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(III) |
57015 |
3-chloro-6-(1-piperazinyl)pyridazine
|
|
C8H11ClN4 |
详情 |
详情
|
(IV) |
53381 |
3-chloro-6-(4-methyl-1-piperazinyl)pyridazine
|
27464-17-1 |
C9H13ClN4 |
详情 | 详情
|
合成路线64
该中间体在本合成路线中的序号:
The antibacterial activity of RBx-7644 is due to the 5(S)-acetamidomethyl configuration at the oxazolidinone ring, and thus, asymmetric synthesis of only the 5(S)-enantiomer was desirable:
3,4-Difluoronitrobenzene (I) is condensed with piperazine in acetonitrile to give 4-(2-fluoro-4-nitrophenyl)-piperazine (II) as a light yellow compound. Compound (II) is dissolved in dichloromethane and triethylamine, followed by the addition of Boc-anhydride, to provide compound (III). 4-(tert-Butoxycarbonyl)-1-(2-fluoro-4-nitrophenyl)piperazine (III), upon hydrogenation with H2 over Pd/C in methanol at 50 psi, yields 4-(tert-butoxycarbonyl)-1-(2-fluoro-4-aminophenyl)piperazine (IV) as a dark solid. Compound (IV) reacts with benzylchloroformate in dry THF in the presence of solid sodium bicarbonate to afford the desired compound (V). 4-(tert-Butoxycarbonyl)-1-[2-fluoro-4-(benzyloxycarbonylamino)phenyl]piperazine (V), upon treatment with n-BuLi and (R)-glycidyl butyrate at -78 °C, gives the desired (R)-(-)-3-[3-fluoro-4-[4-(tert-butoxycarbonyl)piperazin-1-yl]phenyl]-5-(hydroxymethyl)-2-oxazolidinone (VI). The hydroxymethyl compound (VI) is treated with methanesulfonyl chloride in dichloromethane in the presence of triethylamine to give (R)-(-)-3-[3-fluoro-4-[4-(tert-butoxycarbonyl)piperazin-1-yl]phenyl]-5-(methylsulfonyloxymethyl)-2-oxazolidinone (VII). The sulfonyl derivative (VII) is treated with sodium azide in dimethylformamide to provide the azide (VIII) as a white solid. (R)-(-)-3-[3-Fluoro-4-[4-(tert-butoxycarbonyl)piperazin-1-yl)phenyl]-5-(azidomethyl)-2-oxazolidinone (VIII), upon hydrogenation with H2 over Pd/C at 45 psi, gives (S)-(-)-3-[3-fluoro-4-[4-(tert-butoxycarbonyl)-piperazin-1-yl]phenyl]-5-(aminomethyl)-2-oxazolidinone (IX). The aminomethyl compound (IX), upon treatment with acetic anhydride in dichloromethane in the presence of triethylamine, affords the acetamide derivative (X). The acetamidomethyl-oxazolidinone derivative (X), upon treatment with trifluoroacetic acid, gives (S)-(-)-3-[3-fluoro-4-(1-piperazinyl)phenyl]-5-(acetamidomethyl)-2-oxazolidinone, which, without isolation, is treated with 5-nitro-2-furaldehyde in the presence of sodium triacetoxy borohydride to provide compound (XI). Compound (XI), upon treatment with ethanolic HCl, affords RBx-7644 as a light yellow crystalline solid.
【1】
Rattan, A.; RBx-7644. Drugs Fut 2003, 28, 11, 1070.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10101 |
Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene
|
501-53-1 |
C8H7ClO2 |
详情 | 详情
|
|
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
|
18385 |
(2R)oxiranylmethyl butyrate;(R)-glycidyl butyrate |
60456-26-0 |
C7H12O3 |
详情 | 详情
|
|
51375 |
5-Nitro-2-furaldehyde; 5-Nitrofurfural
|
698-63-5 |
C5H3NO4 |
详情 | 详情
|
(I) |
17013 |
1,2-difluoro-4-nitrobenzene; 3,4-Difluoronitrobenzene
|
369-34-6 |
C6H3F2NO2 |
详情 | 详情
|
(II) |
18382 |
1-(2-fluoro-4-nitrophenyl)piperazine
|
|
C10H12FN3O2 |
详情 |
详情
|
(III) |
63060 |
tert-butyl 4-(2-fluoro-4-nitrophenyl)-1-piperazinecarboxylate
|
|
C15H20FN3O4 |
详情 |
详情
|
(IV) |
63061 |
tert-butyl 4-(4-amino-2-fluorophenyl)-1-piperazinecarboxylate
|
|
C15H22FN3O2 |
详情 |
详情
|
(V) |
63062 |
tert-butyl 4-(4-{[(benzyloxy)carbonyl]amino}-2-fluorophenyl)-1-piperazinecarboxylate
|
|
C23H28FN3O4 |
详情 |
详情
|
(VI) |
63063 |
tert-butyl 4-{2-fluoro-4-[(5R)-5-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}-1-piperazinecarboxylate
|
|
C19H26FN3O5 |
详情 |
详情
|
(VII) |
63064 |
tert-butyl 4-[2-fluoro-4-((5R)-5-{[(methylsulfonyl)oxy]methyl}-2-oxo-1,3-oxazolidin-3-yl)phenyl]-1-piperazinecarboxylate
|
|
C20H28FN3O7S |
详情 |
详情
|
(X) |
63067 |
tert-butyl 4-(4-{(5S)-5-[(acetylamino)methyl]-2-oxo-1,3-oxazolidin-3-yl}-2-fluorophenyl)-1-piperazinecarboxylate
|
|
C21H29FN4O5 |
详情 |
详情
|
(XI) |
63068 |
N-{[(5S)-3-(3-fluoro-4-{4-[(5-nitro-2-furyl)methyl]-1-piperazinyl}phenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide
|
|
C21H24FN5O6 |
详情 |
详情
|
合成路线65
该中间体在本合成路线中的序号:
(II) Condensation of 4-fluorobenzonitrile (I) with piperazine (II) in hot DMSO gives rise to the dinitrile adduct (III). This is then converted into imidate (IV) with HCl/EtOH. Treatment of imidate (IV) with ethanolic ammonia furnishes the corresponding bis-amidine derivative, which is finally isolated as the dihydrochloride salt. (1,2)
【1】
Tao, B.; Huang, T.L.; Zhang, Q.; Jackson, L.; Queener, S.F.; Donkor, I.O.; Synthesis and anti-Pneumocystis carinii activity of conformationally restricted analogues of pentamidine. Eur J Med Chem 1999, 34, 6, 531.
|
【2】
Donkor, I.O.; Huang, T.L.; Tao, B.; Rattendi, D.; Lane, S.; Vargas, M.; Goldberg, B.; Bacchi, C.; Trypanocidal activity of conformationally restricted pentamidine congeners. J Med Chem 2003, 46, 6, 1041.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14144 |
4-Fluorobenzonitrile
|
1194-02-1 |
C7H4FN |
详情 | 详情
|
(II) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(III) |
64041 |
4-[4-(4-cyanophenyl)-1-piperazinyl]benzonitrile
|
|
C18H16N4 |
详情 |
详情
|
(IV) |
64042 |
ethyl 4-(4-{4-[ethoxy(imino)methyl]phenyl}-1-piperazinyl)benzenecarboximidoate
|
|
C22H28N4O2 |
详情 |
详情
|
合成路线66
该中间体在本合成路线中的序号:
(II) Reductive amination of 6-methoxy-1-indanone (I) with piperazine (II) in the presence of titanium isopropoxide and NaBH4 furnishes the indanyl piperazine (III). Racemic amine (III) is then resolved employing (S)-10-camphorsulfonic acid to provide the (R)-enantiomer (IV). Condensation of the optically active piperazine (IV) with ethyl isocyanate then affords the target urea (1-3).
【1】
Mattson, R.J.; Catt, J.D.; Keavy, D.; Sloan, C.P.; Epperson, J.; Gao, Q.; Hodges, D.B.; Iben, L.; Mahle, C.D.; Ryan, E.; Yocca, F.D.; Indanyl piperazines as melatonergic MT2 selective agents. Bioorg Med Chem Lett 2003, 13, 6, 1199.
|
【2】
Mattson, R.J.; Sloan, C.P.; Catt, J.D. (Bristol-Myers Squibb Co.); Novel melatonergic indanyl piperazines or homopiperazines. CA 2175395; EP 0745597 .
|
【3】
Mattson, R.J.; Catt, J.D. (Bristol-Myers Squibb Co.); Melatonergic indanyl piperazines. US 5780470 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
64586 |
1-nitrosoethane
|
|
C2H5NO |
详情 |
详情
|
(I) |
34514 |
6-methoxy-1-indanone
|
13623-25-1 |
C10H10O2 |
详情 | 详情
|
(II) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(III) |
64353 |
1-(6-methoxy-2,3-dihydro-1H-inden-1-yl)piperazine; methyl 3-(1-piperazinyl)-2,3-dihydro-1H-inden-5-yl ether
|
|
C14H20N2O |
详情 |
详情
|
(IV) |
64354 |
1-[(1R)-6-methoxy-2,3-dihydro-1H-inden-1-yl]piperazine; methyl (3R)-3-(1-piperazinyl)-2,3-dihydro-1H-inden-5-yl ether
|
|
C14H20N2O |
详情 |
详情
|
合成路线67
该中间体在本合成路线中的序号:
(XI) Reaction of 2-carboxybenzaldehye (I) with dimethyl phosphite in the presence of MeONa in MeOH affords the isobenzofuranylphosphonate (II), which is condensed with 2-fluoro-5-formylbenzonitrile (III) by means of triethylamine in THF to give the benzylidene-isobenzofuranone (IV). Basic hydrolysis of the nitrile group of compound (IV) followed by treatment with hydrazine hydrate leads to the phthalazinone-carboxylic acid (V) (1-3), which can also be obtained by treatment of isobenzofuranone (IV) first with hydrazine hydrate in THF, followed by hydrolysis of the resulting phthalazinone nitrile (VI) with aqueous NaOH (2). Coupling of carboxylic acid (V) with N-Boc-piperazine (VII) by means of HBTU and DIEA in dimethylacetamide yields the Boc-protected amide (VIII), which is then deprotected to compound (IX) by treatment with HCl in EtOH or MeOH. Finally, piperazine-phthalazinone (IX) is acylated with cyclopropanecarbonyl chloride (X) in the presence of triethylamine or DIEA in CH2Cl2 (1, 2). Alternatively, condensation of piperazine (XI) with cyclopropanecarbonyl chloride (X) in AcOH solution gives N-(cyclopropylcarbonyl)piperazine (XII) (2), which is then coupled with the phthalazinone-carboxylic acid (V) by means of HBTU and DIEA in acetonitrile or dimethylacetamide (2, 3). Scheme 1.
【1】
Martin, N.M.B., Smith, G.C.M., Jackson, S.P. et al. (KuDOS Pharmaceuticals Ltd.; Maybridge Ltd.). Phthalazinone derivatives. CA 2517629, EP 1633724, GB 2415430, JP 2006519837, JP 2008001718, US 2005059663, US 2006149059, US 2008200469, US 7449464, WO 2004080976. |
【2】
Menear, K.A., Ottridge, A.P., Londesbrough, D.J. et al. (KuDOS Pharmaceuticals Ltd.). Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one. US 2008146575, WO 2008047082. |
【3】
Menear, K.A., Adcock, C., Boulter, R. et al. 4-[3-(4-Cyclopropanecarbonyl piperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: A novel bioavailable inhibitor of poly (ADP-ribose) polymerase-1. J Med Chem 2008, 51(20): 6581-91. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
65828 |
3-hydroxy-2-benzofuran-1(3H)-one |
|
C8H6O3 |
详情 | 详情
|
(II) |
65829 |
Dimethyl (3-oxo-1,3-dihydroisobenzofuran-1-yl)phosphonate; (3-Oxo-1,3-dihydroisobenzofuran-1-yl)phosphonic acid dimethyl ester |
61260-15-9 |
C10H11O5P |
详情 | 详情
|
(III) |
65830 |
3-Cyano-4-fluorobenzaldehyde; 2-Fluoro-5-formylbenzonitrile |
218301-22-5 |
C8H4FNO |
详情 | 详情
|
(IV) |
65831 |
2-Fluoro-5-[(3-oxo-1(3H)-isobenzofuranylidene)methyl]benzonitrile |
763114-25-6 |
C16H8FNO2 |
详情 | 详情
|
(V) |
65832 |
2-Fluoro-5-(4-oxo-3,4-dihydrophthalazin-1-ylmethyl)benzoic acid |
763114-26-7 |
C16H11FN2O3 |
详情 | 详情
|
(VI) |
65833 |
|
|
C16H10FN3O |
详情 | 详情
|
(VII) |
13225 |
N-tert-Butoxycarbonyl piperazine; tert-butyl 1-piperazinecarboxylate;tert-butyl piperazine-1-carboxylate |
143238-38-4 |
C9H18N2O2 |
详情 | 详情
|
(VIII) |
65834 |
|
|
C25H27FN4O4 |
详情 | 详情
|
(IX) |
65835 |
1-[5-[(3,4-Dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]piperazine |
763111-47-3 |
C20H19FN4O2 |
详情 | 详情
|
(X) |
14061 |
Cyclopropanecarbonyl chloride; Cyclopropanecarboxylic acid chloride
|
4023-34-1 |
C4H5ClO |
详情 | 详情
|
(XI) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(XII) |
65836 |
1-(Cyclopropylcarbonyl)piperazine |
59878-57-8 |
C8H14N2O |
详情 | 详情
|
合成路线68
该中间体在本合成路线中的序号:
(I)
【1】
Deshpande PB, Chauhan AJ. 2006. Crystalline and amorphous form of ranolazine and the process for manufacturing them. WO 2006008753 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(II) |
24103 |
2-[(2-methoxyphenoxy)methyl]oxirane
|
|
C10H12O3 |
详情 |
详情
|
(III) |
24109 |
1-(2-methoxyphenoxy)-3-(1-piperazinyl)-2-propanol
|
|
C14H22N2O3 |
详情 |
详情
|
(IV) |
24100 |
2-chloro-N-(2,6-dimethylphenyl)acetamide
|
2198-53-0 |
C10H12ClNO |
详情 | 详情
|
合成路线69
该中间体在本合成路线中的序号:
(VI) Condensation of 2-bromoiodobenzene (I) with 2,4-dimethylthiophenol (II) by means of either Pd2(dba)3 or Pd(dba)2, t-BuOK and DPEphos or Pd(dba)2, BINAP and t-BuONa in toluene yields 1-(2-bromophenylsulfanyl)-2,4-dimethylbenzene (III) , which alternatively can be prepared by reaction of either 1-iodo- or 1-bromo-2,4-dimethylbenzene (IVa or IVb) with 2-bromobenzenethiol (V) in the presence of Pd2(dba)3 and DPEphos . Then, aryl bromide (III) is condensed with piperazine (VI) in the presence of Pd(dba)2, BINAP and t-BuONa in toluene to give the free base (VII) , which is finally treated with HBr in MeOH , EtOAc or toluene .
The free base (VII) can be alternatively prepared in a one-pot procedure by reaction of 2-bromoiodobenzene (I) with 2,4-dimethylthiophenol (II) and piperazine (VI) in the presence of Pd(dba)2, BINAP and t-BuONa .
Reaction of 2-bromoiodobenzene (I) with N-Boc-piperazine (VIII) by means of Pd2(dba)3 and xantphos affords the arylpiperazine (IX) , which is then condensed with 2,4-dimethylthiophenol (II) in the presence of Pd2(dba)3, t-BuOK and DPEphos in toluene at 100 °C to give the thioether (X) . Finally, compound (X) is submitted to N-deprotection with HBr in refluxing H2O .
Alternatively, reaction of thioether (III) with N-Boc-piperazine (VIII) in the presence of Pd(dba)2 or Pd2(dba)3, BINAP , and optionally, t-BuONa in toluene , provides the N-Boc-protected arylpiperazine (X), which is then N-deprotected with HCl in refluxing MeOH to give the free base (VII) .
In a solid-phase method, binding of piperazine (VI) to the p-nitrophenyl carbonate resin (XI) in the presence of NMM in DMF results in the 4-[(1-piperazinyl)carboxymethyl]phenoxymethyl polystyrene (XII), which is then condensed with [η6-1,2-dichloro-benzene][η5-cyclopentadienyl] iron hexafluorophosphate (XIII) in the presence of K2CO3 in THF to afford the N,N’-disubstituted piperazine (XIV). Finally, the resin-bound piperazine (XIV) is condensed with 2,4-dimethylthiophenol (II) (previously treated with NaH), and subsequently subjected to photolytic decomplexation, and further acidic cleavage from the resin (TFA/CH2Cl2), leading to the free base (VII) .
【1】
Bang-Andersen, B., Faldt, A., Moerk, A. et al. (H. Lundbeck A/S). 1-[2-(2,4-Dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment. EP 2044043, JP 2009541216, JP 2010090165, US 2010297240, WO 2007144005. |
【2】
Bang-Andersen, B., Ruhland, T., Smith, G. et al. Discovery of Lu AA21004: A novel compound for the treatment of mood disorders. 237th ACS Natl Meet (March 22-2, Salt Lake City) 2009, Abst MEDI 103. |
【3】
Moore, N., Stensboel, T.B. (H. Lundbeck A/S). 1-[2-(2,4-Dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition. CA 2684571, EP 2142193, JP 201052501, US 2011009422, WO 2008113359. |
【4】
Nicolajsen, H.V., Lopez de Diego, H., Rock, M.H. (H. Lundbeck A/S). Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine. WO 2010094285. |
【5】
Bang-Andersen, B., Ruhland, T., Jorgensen, M. et al. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (LU AA21004): A novel multimodal compound for the treatment of major depressive disorder. J Med Chem 2011 54(9): 3206-21. |
【6】
Smith, G.P., Pueschl, A., Moltzen, E.K., Ruhland, T., Bang-Andersen, B., Andersen, K. (H. Lundbeck A/S). Phenyl-piperazine derivatives as serotonin reuptake inhibitors. EP 1436271, EP 1749818, JP 2005505585, JP 2007031447, JP 2007051149, US 2006084662, US 2006089368, US 7138407, US 7144884, US 7148238, US 2007060574, US 7683053, US 2011009423, WO 2003029232. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IVa) |
68826 |
1-iodo-2,4-dimethylbenzene;2,4-Dimethyliodobenzene;1,3-Dimethyl-4-iodobenzene;4-Iodo-m-xylene |
4214-28-2 |
C8H9I |
详情 | 详情
|
(IVb) |
68827 |
1-bromo-2,4-dimethylbenzene;2,4-Dimethylbromobenzene;4-Bromo-1,3-dimethylbenzene;4-Bromo-m-xylene |
583-70-0 |
C8H9Br |
详情 | 详情
|
(I) |
68823 |
2-bromoiodobenzene;o-Iodobromobenzene;o-Bromophenyl iodide;o-Bromoiodobenzene;2-Iodobromobenzene;2-Bromophenyliodide;2-Bromo-1-iodobenzene;1-Iodo-2-bromobenzene;1-Bromo-2-iodobenzene |
583-55-1 |
C6H4BrI |
详情 | 详情
|
(II) |
68824 |
2,4-dimethylthiophenol;2,4-Dimethylbenzenethiol |
13616-82-5 |
C8H10S |
详情 | 详情
|
(III) |
68825 |
1-(2-bromophenylsulfanyl)-2,4-dimethylbenzene;(2-bromophenyl)(2,4-dimethylphenyl)sulfane |
|
C14H13BrS |
详情 |
详情
|
(V) |
52030 |
2-Bromobenzenethiol; 2-Bromothiophenol;2-bromo-benzenethio;2-Bromo thiophenol |
6320-02-1 |
C6H5BrS |
详情 | 详情
|
(VI) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(VII) |
68828 |
1-(2-((2,4-dimethylphenyl)thio)phenyl)piperazine |
|
C18H22N2S |
详情 | 详情
|
(VIII) |
13225 |
N-tert-Butoxycarbonyl piperazine; tert-butyl 1-piperazinecarboxylate;tert-butyl piperazine-1-carboxylate |
143238-38-4 |
C9H18N2O2 |
详情 | 详情
|
(IX) |
68829 |
tert-butyl 4-(2-bromophenyl)piperazine-1-carboxylate;1-BOC-4-(2-Bromophenyl)piperazine;4-(2-BROMO-PHENYL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER |
494773-35-2 |
C15H21BrN2O2 |
详情 | 详情
|
(X) |
68830 |
tert-butyl 4-(2-((2,4-dimethylphenyl)thio)phenyl)piperazine-1-carboxylate |
|
C23H30N2O2S |
详情 | 详情
|
(XII) |
68831 |
4-[(1-piperazinyl)carboxymethyl]phenoxymethyl polystyrene |
|
|
详情 | 详情
|
(XIII) |
68832 |
[η6-1,2-dichloro-benzene][η5-cyclopentadienyl]iron hexafluorophosphate |
|
|
详情 | 详情
|